{
  "usdmVersion": "4.0",
  "generatedAt": "2025-12-16T22:42:05.299816",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "dd75d106-2924-4d54-ae5b-f325acfbf727",
    "instanceType": "Study",
    "versions": [
      {
        "id": "1a7814e5-25dd-44e8-aa20-271e2bd47ab7",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "923f6c0c-e811-4d45-9a53-2f0cadb97ad6",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "c8550380-a822-4413-82d4-9d84c634cd8b",
              "standardCode": {
                "id": "ba8ab5ae-c5d9-4ee8-8623-5da65cf281e7",
                "code": "Open Label",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Open Label",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Non-Randomized"
            },
            "arms": [
              {
                "id": "c4a7a105-13d0-4458-9c9d-7f0b474d8962",
                "name": "Cohort A",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants receive subcutaneous ramucirumab to evaluate PK and safety",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "210214e5-0d72-4553-8c6e-15dd4a225856",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "cc23aeaa-c96e-4732-908b-63a3c894817f",
                "name": "Sub-Cohort B1",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants receive subcutaneous ramucirumab at a second dose level to generate PK data to inform dosing strategy for Sub-Cohort B2",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "64512ccf-cd45-4f93-9417-161f7c06005f",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "b756b75d-42ab-47f0-a72e-2e78afbcde07",
                "name": "Sub-Cohort B2",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants receive subcutaneous ramucirumab with loading dose and maintenance weekly dose based on Sub-Cohort B1 results",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "98922fe4-3654-47f8-8438-e343a5b50bea",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "98010ebb-4338-44d3-9ee4-0ed2f50962cf",
                "name": "Sub-Cohort B3",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants receive subcutaneous ramucirumab with dose that may be adjusted",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "a2ced1a5-14f5-4542-83f6-05389dadf2b7",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "b0f15fb5-4cb2-469b-b442-617aa7110772",
                "name": "Cohort C",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Participants receive subcutaneous ramucirumab alone or in combination with additional anti-cancer therapy",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "f8b01085-b50e-46d4-ba3f-47b418804b5e",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "c1642cb4-03ab-4af9-a18c-e0bf4119dac6",
                "name": "Cohort A",
                "instanceType": "StudyCohort",
                "characteristic": "Initial cohort for PK and safety evaluation of SC ramucirumab"
              },
              {
                "id": "c8a10e42-4c60-4b7b-9375-19c1db515fb6",
                "name": "Cohort B",
                "instanceType": "StudyCohort",
                "characteristic": "Expansion cohort to investigate additional dosing regimens, comprising Sub-Cohorts B1, B2, and B3"
              },
              {
                "id": "0a25d0f7-ea1f-43f7-bb1f-109a7bcd59da",
                "name": "Cohort C",
                "instanceType": "StudyCohort",
                "characteristic": "Cohort for SC ramucirumab alone or in combination with additional anti-cancer therapy"
              }
            ],
            "studyCells": [
              {
                "id": "a643b351-3396-4bce-9e8e-75d7fba1bf97",
                "armId": "c4a7a105-13d0-4458-9c9d-7f0b474d8962",
                "epochId": "0aa62bb4-7859-4cc0-9d38-928cd554c00c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "34f0b16c-d29a-44b9-821c-435556c4800d",
                "armId": "c4a7a105-13d0-4458-9c9d-7f0b474d8962",
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "9214c3c9-a857-4cb7-9020-41b3a394c5ec",
                "armId": "c4a7a105-13d0-4458-9c9d-7f0b474d8962",
                "epochId": "b3753bb6-f9e7-4fa0-9eed-78cff39dac4c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "c61a9860-ea4c-416c-b2f9-edf4027f080d",
                "armId": "cc23aeaa-c96e-4732-908b-63a3c894817f",
                "epochId": "0aa62bb4-7859-4cc0-9d38-928cd554c00c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "cdac5678-080d-4bb3-b9a2-22f53c42df93",
                "armId": "cc23aeaa-c96e-4732-908b-63a3c894817f",
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "4a4ade1d-1fc9-4fff-b240-b81557a4b5af",
                "armId": "cc23aeaa-c96e-4732-908b-63a3c894817f",
                "epochId": "b3753bb6-f9e7-4fa0-9eed-78cff39dac4c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "e21774f2-6f7f-47ab-ad4e-97d162aab79a",
                "armId": "b756b75d-42ab-47f0-a72e-2e78afbcde07",
                "epochId": "0aa62bb4-7859-4cc0-9d38-928cd554c00c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "63901d4c-09b7-40cc-8f59-a43a23ff175f",
                "armId": "b756b75d-42ab-47f0-a72e-2e78afbcde07",
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "d2f298d8-6a70-4e8f-8dbe-95886863e1e8",
                "armId": "b756b75d-42ab-47f0-a72e-2e78afbcde07",
                "epochId": "b3753bb6-f9e7-4fa0-9eed-78cff39dac4c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "033b1f6d-3394-4313-8a1c-cafbbc5f47b7",
                "armId": "98010ebb-4338-44d3-9ee4-0ed2f50962cf",
                "epochId": "0aa62bb4-7859-4cc0-9d38-928cd554c00c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "35755507-a8a6-421d-9210-b999ac5e5209",
                "armId": "98010ebb-4338-44d3-9ee4-0ed2f50962cf",
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "da610602-a5a0-4600-aeee-9379f3335e41",
                "armId": "98010ebb-4338-44d3-9ee4-0ed2f50962cf",
                "epochId": "b3753bb6-f9e7-4fa0-9eed-78cff39dac4c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "01eea26e-0881-4240-88a3-618f725210a9",
                "armId": "b0f15fb5-4cb2-469b-b442-617aa7110772",
                "epochId": "0aa62bb4-7859-4cc0-9d38-928cd554c00c",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "28c0fa83-4ef5-4b34-a529-782223ac747c",
                "armId": "b0f15fb5-4cb2-469b-b442-617aa7110772",
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "ae361369-de60-4b91-be1c-6a012a7dd74c",
                "armId": "b0f15fb5-4cb2-469b-b442-617aa7110772",
                "epochId": "b3753bb6-f9e7-4fa0-9eed-78cff39dac4c",
                "elementIds": [],
                "instanceType": "StudyCell"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "12e4623f-0b65-4c09-be13-f54d8caa2aec",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b7d8872b-a27a-4429-98dc-7346bb988826",
                "instanceType": "EligibilityCriterion",
                "name": "Histological or cytological confirmation of cancer",
                "nextId": "6c6514eb-b3f0-43eb-98dd-61cedbb65cec"
              },
              {
                "id": "6c6514eb-b3f0-43eb-98dd-61cedbb65cec",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "a632c491-0057-40cc-bb4f-303a9f3c96fc",
                "instanceType": "EligibilityCriterion",
                "name": "Refractory/relapsed solid tumors",
                "previousId": "12e4623f-0b65-4c09-be13-f54d8caa2aec",
                "nextId": "113b7447-ac18-4c83-8bc9-aed55c31c5b7"
              },
              {
                "id": "113b7447-ac18-4c83-8bc9-aed55c31c5b7",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b157c1ac-6905-4737-8211-8af340e3d411",
                "instanceType": "EligibilityCriterion",
                "name": "Measurable disease",
                "previousId": "6c6514eb-b3f0-43eb-98dd-61cedbb65cec",
                "nextId": "cdf32865-ce3d-4fad-bd28-fbe0e17e389f"
              },
              {
                "id": "cdf32865-ce3d-4fad-bd28-fbe0e17e389f",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e3fb3f80-cf3b-4ee6-bfb2-4bdc9d30805a",
                "instanceType": "EligibilityCriterion",
                "name": "ECOG performance status",
                "previousId": "113b7447-ac18-4c83-8bc9-aed55c31c5b7",
                "nextId": "11d336e1-eb30-46a9-9e5a-b7b4884b809d"
              },
              {
                "id": "11d336e1-eb30-46a9-9e5a-b7b4884b809d",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "f956ab9c-3b02-4510-aeaf-aef388f2229e",
                "instanceType": "EligibilityCriterion",
                "name": "Life expectancy",
                "previousId": "cdf32865-ce3d-4fad-bd28-fbe0e17e389f",
                "nextId": "f36a84af-fa39-4491-a4c5-701283a00ae6"
              },
              {
                "id": "f36a84af-fa39-4491-a4c5-701283a00ae6",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "62f6ca70-a696-4513-a3f0-7214f6b343cd",
                "instanceType": "EligibilityCriterion",
                "name": "Adequate organ function",
                "previousId": "11d336e1-eb30-46a9-9e5a-b7b4884b809d",
                "nextId": "836e1fa3-e221-4a72-b0d9-822ca1432673"
              },
              {
                "id": "836e1fa3-e221-4a72-b0d9-822ca1432673",
                "identifier": "7",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "165c14e3-3310-49b3-b89f-1b13abbdd90b",
                "instanceType": "EligibilityCriterion",
                "name": "Recovery from prior therapy toxicities",
                "previousId": "f36a84af-fa39-4491-a4c5-701283a00ae6",
                "nextId": "b1aba031-af6d-4d4e-b35e-43cbd2c883eb"
              },
              {
                "id": "b1aba031-af6d-4d4e-b35e-43cbd2c883eb",
                "identifier": "8",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "79eb7511-50a1-4f69-b12c-8b82398a3d54",
                "instanceType": "EligibilityCriterion",
                "name": "Urinary protein requirement",
                "previousId": "836e1fa3-e221-4a72-b0d9-822ca1432673",
                "nextId": "13bfe991-a1b9-48fe-811a-3c2fb4bfe902"
              },
              {
                "id": "13bfe991-a1b9-48fe-811a-3c2fb4bfe902",
                "identifier": "9",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "881e2569-6cff-42ad-b0f5-03a2e583b16c",
                "instanceType": "EligibilityCriterion",
                "name": "Sex",
                "previousId": "b1aba031-af6d-4d4e-b35e-43cbd2c883eb",
                "nextId": "dde752d5-f75f-444e-b76c-09d4afa566de"
              },
              {
                "id": "dde752d5-f75f-444e-b76c-09d4afa566de",
                "identifier": "10",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4e04cf3e-2a20-45df-833f-46080be3a607",
                "instanceType": "EligibilityCriterion",
                "name": "Informed Consent",
                "previousId": "13bfe991-a1b9-48fe-811a-3c2fb4bfe902"
              },
              {
                "id": "5b7c2991-8552-47ec-9a84-8fe7fb03082a",
                "identifier": "11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "398a6a50-2c97-40b0-badd-44853fe56609",
                "instanceType": "EligibilityCriterion",
                "name": "Uncontrolled hypertension",
                "nextId": "02e03101-061e-4b52-83a8-6a4b7f66cb90"
              },
              {
                "id": "02e03101-061e-4b52-83a8-6a4b7f66cb90",
                "identifier": "12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "ca494129-50c0-41df-a4a0-f0269d6e97d8",
                "instanceType": "EligibilityCriterion",
                "name": "Significant bleeding disorders",
                "previousId": "5b7c2991-8552-47ec-9a84-8fe7fb03082a",
                "nextId": "8cd9d4b6-9549-4c4f-b08d-2e3ef6770805"
              },
              {
                "id": "8cd9d4b6-9549-4c4f-b08d-2e3ef6770805",
                "identifier": "13",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "62e3dcc8-c3fa-44f3-99df-34351238d94d",
                "instanceType": "EligibilityCriterion",
                "name": "Hepatic impairment",
                "previousId": "02e03101-061e-4b52-83a8-6a4b7f66cb90",
                "nextId": "487b03bf-4c93-4995-9abe-39ed8333ef6a"
              },
              {
                "id": "487b03bf-4c93-4995-9abe-39ed8333ef6a",
                "identifier": "14",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "06d14e13-67d2-4cf7-b4b6-de5980a5abd8",
                "instanceType": "EligibilityCriterion",
                "name": "Arterial thromboembolic events",
                "previousId": "8cd9d4b6-9549-4c4f-b08d-2e3ef6770805",
                "nextId": "5708f20c-cd3b-4d3f-801f-50ad5ef8001d"
              },
              {
                "id": "5708f20c-cd3b-4d3f-801f-50ad5ef8001d",
                "identifier": "15",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5792727b-5ece-4e6a-bf71-9141110edaff",
                "instanceType": "EligibilityCriterion",
                "name": "Congestive heart failure or cardiac arrhythmia",
                "previousId": "487b03bf-4c93-4995-9abe-39ed8333ef6a",
                "nextId": "afa315f4-63dc-4cbd-8c52-ceafe3a16907"
              },
              {
                "id": "afa315f4-63dc-4cbd-8c52-ceafe3a16907",
                "identifier": "16",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "09e37ade-1167-4e48-b083-0019d1fa6f03",
                "instanceType": "EligibilityCriterion",
                "name": "Serious concomitant systemic disorder",
                "previousId": "5708f20c-cd3b-4d3f-801f-50ad5ef8001d",
                "nextId": "48492ceb-3f93-4cc9-a228-68a63429c612"
              },
              {
                "id": "48492ceb-3f93-4cc9-a228-68a63429c612",
                "identifier": "17",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "f511007e-305c-4cec-a5a7-4bb646905a38",
                "instanceType": "EligibilityCriterion",
                "name": "Active infection requiring systemic therapy",
                "previousId": "afa315f4-63dc-4cbd-8c52-ceafe3a16907",
                "nextId": "a729a505-5c01-4109-8354-ba35cfd9ef29"
              },
              {
                "id": "a729a505-5c01-4109-8354-ba35cfd9ef29",
                "identifier": "18",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "87f5edfc-06a8-4f23-8933-817635ec7b26",
                "instanceType": "EligibilityCriterion",
                "name": "HIV positive participants",
                "previousId": "48492ceb-3f93-4cc9-a228-68a63429c612",
                "nextId": "32e5851c-5d0a-4836-a6f8-e893c81bf601"
              },
              {
                "id": "32e5851c-5d0a-4836-a6f8-e893c81bf601",
                "identifier": "19",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c2164880-782b-428a-9294-1f5fa2b38e2a",
                "instanceType": "EligibilityCriterion",
                "name": "Chronic active hepatitis B or C",
                "previousId": "a729a505-5c01-4109-8354-ba35cfd9ef29",
                "nextId": "0964dddc-57ae-4457-9420-5929372ac149"
              },
              {
                "id": "0964dddc-57ae-4457-9420-5929372ac149",
                "identifier": "20",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "ae5ba90f-6661-413a-be8d-a326bfb8b7c6",
                "instanceType": "EligibilityCriterion",
                "name": "Prior or second concurrent primary malignancies",
                "previousId": "32e5851c-5d0a-4836-a6f8-e893c81bf601",
                "nextId": "3d264309-7f62-4aef-be51-d5a43b4c6941"
              },
              {
                "id": "3d264309-7f62-4aef-be51-d5a43b4c6941",
                "identifier": "21",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b4db53e0-9317-46fc-bb00-305b008ca523",
                "instanceType": "EligibilityCriterion",
                "name": "Symptomatic CNS malignancy or metastasis",
                "previousId": "0964dddc-57ae-4457-9420-5929372ac149",
                "nextId": "4c78315e-6867-4a42-998b-8c299a7c244e"
              },
              {
                "id": "4c78315e-6867-4a42-998b-8c299a7c244e",
                "identifier": "22",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "a353e552-e655-4b38-877d-dbab20314823",
                "instanceType": "EligibilityCriterion",
                "name": "History of GI perforation and/or fistula",
                "previousId": "3d264309-7f62-4aef-be51-d5a43b4c6941",
                "nextId": "9f499b2a-8ebb-4822-8fc6-cf8a8f1d17b1"
              },
              {
                "id": "9f499b2a-8ebb-4822-8fc6-cf8a8f1d17b1",
                "identifier": "23",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "cb3dbe75-7276-4ec9-812d-cf4ff3c40132",
                "instanceType": "EligibilityCriterion",
                "name": "Serious or non-healing wound, ulcer, or bone fracture",
                "previousId": "4c78315e-6867-4a42-998b-8c299a7c244e",
                "nextId": "1444d6aa-2de5-4614-9b70-613199f93490"
              },
              {
                "id": "1444d6aa-2de5-4614-9b70-613199f93490",
                "identifier": "24",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "bb2bd704-aa14-4602-a194-b6e206e921e9",
                "instanceType": "EligibilityCriterion",
                "name": "Chronic therapy with NSAIDs or antiplatelet agents",
                "previousId": "9f499b2a-8ebb-4822-8fc6-cf8a8f1d17b1",
                "nextId": "76caa929-01dd-4063-992f-6b068f9fd797"
              },
              {
                "id": "76caa929-01dd-4063-992f-6b068f9fd797",
                "identifier": "25",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8905fb0f-d8dc-4663-945f-502e412a2e56",
                "instanceType": "EligibilityCriterion",
                "name": "Prior treatment with IV ramucirumab",
                "previousId": "1444d6aa-2de5-4614-9b70-613199f93490",
                "nextId": "b956f164-a739-4177-8b88-c7a0325d806b"
              },
              {
                "id": "b956f164-a739-4177-8b88-c7a0325d806b",
                "identifier": "26",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d9f5103f-4cfa-4e68-bcea-6d7039fac0f6",
                "instanceType": "EligibilityCriterion",
                "name": "Recent participation in clinical study with investigational product",
                "previousId": "76caa929-01dd-4063-992f-6b068f9fd797",
                "nextId": "bab5cc6f-9ca4-4368-b40c-e8cb1851fb14"
              },
              {
                "id": "bab5cc6f-9ca4-4368-b40c-e8cb1851fb14",
                "identifier": "27",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5f7ee111-c7b3-445a-8030-7b373d200a16",
                "instanceType": "EligibilityCriterion",
                "name": "Tattoos or scars over abdomen interfering with injection site assessments",
                "previousId": "b956f164-a739-4177-8b88-c7a0325d806b",
                "nextId": "9fc3c63f-0181-46bc-91ab-b82db9ee9240"
              },
              {
                "id": "9fc3c63f-0181-46bc-91ab-b82db9ee9240",
                "identifier": "28",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0b13939b-da6d-4cde-b2e6-8617c6a2d739",
                "instanceType": "EligibilityCriterion",
                "name": "Elective or planned major surgery",
                "previousId": "bab5cc6f-9ca4-4368-b40c-e8cb1851fb14",
                "nextId": "bac10af7-52f2-45f3-a3ad-d5a4d77e667d"
              },
              {
                "id": "bac10af7-52f2-45f3-a3ad-d5a4d77e667d",
                "identifier": "29",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "9b732040-3552-4c59-b66c-cbcacf9f4d4b",
                "instanceType": "EligibilityCriterion",
                "name": "Major blood vessel invasion or encasement by cancer (NSCLC)",
                "previousId": "9fc3c63f-0181-46bc-91ab-b82db9ee9240",
                "nextId": "638e4005-0ded-4971-8b47-422b2dc2da58"
              },
              {
                "id": "638e4005-0ded-4971-8b47-422b2dc2da58",
                "identifier": "30",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c22e68a1-4178-4e36-ae30-ff40f7657471",
                "instanceType": "EligibilityCriterion",
                "name": "Intratumor cavitation (NSCLC)",
                "previousId": "bac10af7-52f2-45f3-a3ad-d5a4d77e667d",
                "nextId": "7d23fb67-023a-47c4-aced-9c83e3d23450"
              },
              {
                "id": "7d23fb67-023a-47c4-aced-9c83e3d23450",
                "identifier": "31",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b7c1a461-7706-4ab5-aa42-b23098a1216e",
                "instanceType": "EligibilityCriterion",
                "name": "History of gross hemoptysis (NSCLC)",
                "previousId": "638e4005-0ded-4971-8b47-422b2dc2da58"
              }
            ],
            "objectives": [
              {
                "id": "3f95839c-2b0e-4351-9ee9-c5fb38360790",
                "name": "Primary Pharmacokinetic Objective",
                "text": "To evaluate the pharmacokinetics (PK) of subcutaneous (SC) ramucirumab in participants with cancer",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "75e141c6-e082-4c14-ad56-bbece0d0b6ec",
                  "68b52ecb-c48f-4fc9-a093-bc24f738258b",
                  "3f597a86-368c-4ceb-b351-a2accdda480c"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "6a7ebb51-9c9e-45f0-98bc-2a76bd32b10a",
                "name": "Primary Safety Objective",
                "text": "To evaluate the safety of SC ramucirumab in participants with cancer, alone or in combination with additional anti-cancer therapy",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "ca5b4184-61a3-4bc3-a30d-faa718c1a21d",
                  "c61d6d97-dffe-4333-ab5a-b00752a2b5b2"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "8468a4b3-896f-4d34-b288-88c20894d2a4",
                "name": "Secondary Efficacy Objective",
                "text": "To evaluate the efficacy of SC ramucirumab in participants with cancer",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "eb819df1-6587-4e52-b15c-df7df6aeb32d",
                  "09d4cac1-7bfb-444a-9479-2247fcded246"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "274732ab-9ec2-4e5b-bdde-245184866407",
                "name": "Exploratory Immunogenicity Objective",
                "text": "To evaluate the immunogenicity of SC ramucirumab",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "8e035fe2-cbdc-46c9-be10-4ee4209623b1"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "75e141c6-e082-4c14-ad56-bbece0d0b6ec",
                "name": "Ramucirumab Ctrough",
                "text": "Ramucirumab trough concentration (Ctrough) following SC administration",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "68b52ecb-c48f-4fc9-a093-bc24f738258b",
                "name": "Ramucirumab AUC",
                "text": "Ramucirumab area under the plasma concentration versus time curve (AUC) following SC administration",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "3f597a86-368c-4ceb-b351-a2accdda480c",
                "name": "Ramucirumab Cmax",
                "text": "Ramucirumab maximum concentration (Cmax) following SC administration",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "ca5b4184-61a3-4bc3-a30d-faa718c1a21d",
                "name": "Treatment-Emergent Adverse Events",
                "text": "Incidence and severity of treatment-emergent adverse events (TEAEs)",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "c61d6d97-dffe-4333-ab5a-b00752a2b5b2",
                "name": "Injection Site Reactions",
                "text": "Incidence and severity of injection site reactions following SC ramucirumab administration",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "eb819df1-6587-4e52-b15c-df7df6aeb32d",
                "name": "Progression-Free Survival",
                "text": "Progression-free survival (PFS)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "09d4cac1-7bfb-444a-9479-2247fcded246",
                "name": "Overall Survival",
                "text": "Overall survival (OS)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "8e035fe2-cbdc-46c9-be10-4ee4209623b1",
                "name": "Immunogenicity Assessment",
                "text": "Immunogenicity assessments including anti-drug antibody formation",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              }
            ],
            "studyInterventions": [
              {
                "id": "9ffae500-ce19-4e83-885f-127cd8363b7b",
                "name": "Ramucirumab SC",
                "role": {
                  "id": "c49b2ecf-5428-4670-95f7-7cfb24eb2f67",
                  "code": "Investigational Product",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Investigational Product",
                  "instanceType": "Code"
                },
                "instanceType": "StudyIntervention",
                "description": "Subcutaneous formulation of ramucirumab for investigation in participants with cancer",
                "productIds": [
                  "e9962bcd-1fc8-4854-ad4a-d09611395036"
                ],
                "administrationIds": [
                  "81c6fb19-438e-47c9-a033-6f957d3f3cd5"
                ]
              },
              {
                "id": "c4df2f2c-199f-4a51-8ee1-59a383b67759",
                "name": "Paclitaxel",
                "role": {
                  "id": "ec187e80-3fc4-4c66-9520-7daed432d68a",
                  "code": "Concomitant Medication",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Concomitant Medication",
                  "instanceType": "Code"
                },
                "instanceType": "StudyIntervention",
                "description": "Combination anti-cancer treatment administered with ramucirumab SC in eligible participants",
                "administrationIds": [
                  "8cab917b-7dad-47df-a0d3-96c85077175a"
                ]
              },
              {
                "id": "2c5f2f8b-cf8e-4d37-9a57-a33061a8d4a0",
                "name": "FOLFIRI",
                "role": {
                  "id": "91cef3a2-6ad6-4725-a8b8-7236fe712b79",
                  "code": "Concomitant Medication",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Concomitant Medication",
                  "instanceType": "Code"
                },
                "instanceType": "StudyIntervention",
                "description": "Combination anti-cancer treatment administered with ramucirumab SC in eligible participants",
                "administrationIds": [
                  "d3e64b5b-a0b3-4fcc-8aec-01d79f8a032a"
                ]
              },
              {
                "id": "4b27a989-cba5-4029-aaae-6711311456b9",
                "name": "Erlotinib",
                "role": {
                  "id": "8dff19c4-f003-4164-b4e3-f8803af09caa",
                  "code": "Concomitant Medication",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Concomitant Medication",
                  "instanceType": "Code"
                },
                "instanceType": "StudyIntervention",
                "description": "Oral EGFR tyrosine kinase inhibitor administered with ramucirumab SC in eligible participants",
                "administrationIds": [
                  "d96abadb-2c08-47e9-9b48-93b08d9ffcb6"
                ]
              },
              {
                "id": "da14544b-1340-4b29-9fd7-646c4cfd9968",
                "name": "Docetaxel",
                "role": {
                  "id": "b1b72825-3055-452c-93db-4a5b6eb46fd4",
                  "code": "Concomitant Medication",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Concomitant Medication",
                  "instanceType": "Code"
                },
                "instanceType": "StudyIntervention",
                "description": "Combination anti-cancer treatment administered with ramucirumab SC in eligible participants",
                "administrationIds": [
                  "5f8aeb39-9dff-4b3e-95b1-adfff8423c6e"
                ]
              }
            ],
            "scheduleTimelines": [
              {
                "id": "0c9de4a1-cca9-4660-83e9-5de7b99a0b72",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "0303258c-8cf3-4cd5-ba1c-b946de0ab865",
                "instances": [
                  {
                    "id": "0303258c-8cf3-4cd5-ba1c-b946de0ab865",
                    "activityIds": [
                      "42cdc236-991b-41ee-bcd0-fb0cb85a886a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "e349d0aa-9e42-4d78-a38a-bdcde6b551ca",
                    "activityIds": [
                      "68cfdab1-0110-4d56-a05b-b061351413a4"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "06c9f159-c49a-4deb-9aa7-b77615ea4aff",
                    "activityIds": [
                      "215b3c94-0fd3-4b58-a4a1-3f18ee485886"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "f0888442-b3a5-4ed7-b037-efc25fc1d9f3",
                    "activityIds": [
                      "982bea25-8062-4841-875d-c5dd72470734"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "eaecd9f0-6402-4438-8aa1-540da5d3aea9",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "1bf69da4-c040-4146-9bf7-c76080793454",
                    "activityIds": [
                      "42ad366d-d32b-4dd8-9e6a-a11c846215d0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "606f8484-f9c9-4843-b3bb-b0a1e992e677",
                    "activityIds": [
                      "6da409cd-1281-49ea-907b-4a8bc20edba4"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "5896b144-8c8d-4dba-ab41-68d96a182eff",
                    "activityIds": [
                      "40c255bc-3f8e-4d46-bd02-3bd545d99cfe"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "c0e54729-6d65-4b1b-a864-0682d13347b4",
                    "activityIds": [
                      "3595c308-5a07-4aa7-9d6c-42ddc8160ffd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "e6e9aa83-1613-4b47-b43b-49a5fcbb958c",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "d9a0701d-15c2-4e87-9bc6-b007e81ac9ad",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "e3a429ae-e05a-4522-8755-ec0358c6d1be",
                    "activityIds": [
                      "f3394c48-9f98-41b4-85d6-dc6685a47cec"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "795db4f4-e09b-40d5-83b0-4b58c7176865",
                    "activityIds": [
                      "6e112783-383a-4d3b-9b33-78ae4f35cb89"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "1f0b6aa2-1288-46da-b40e-9b9356defb93",
                    "activityIds": [
                      "f8ca4e3d-b60e-4469-86bf-701b5568dd1d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "34f04aec-ca3b-4177-9aeb-46e72f9a8952",
                    "activityIds": [
                      "735813c5-f0f1-4a58-b4f3-ef163b82ba52"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "7d957361-f98d-45f8-b182-97d7596593d1",
                    "activityIds": [
                      "2bfcac8b-af85-4da1-8ead-fa245c0b87fc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_16@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "0af656c6-a364-4b8a-942f-1c1cbf67e8be",
                    "activityIds": [
                      "9774fdde-ba25-4f3f-9d85-6d54bad59551"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_1",
                    "encounterId": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e"
                  },
                  {
                    "id": "08651045-a636-4dab-b045-a549eda1af53",
                    "activityIds": [
                      "982bea25-8062-4841-875d-c5dd72470734"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "6d5a5667-8d54-4cc5-824d-a79f86e7db46",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "64810d3d-19c0-450e-9131-86a4f3a7ddff",
                    "activityIds": [
                      "42ad366d-d32b-4dd8-9e6a-a11c846215d0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "e6fa7dee-9b7d-4bbf-9d4d-9f92eeef9e2d",
                    "activityIds": [
                      "40c255bc-3f8e-4d46-bd02-3bd545d99cfe"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "57a0046f-a896-4183-9830-1a237861af73",
                    "activityIds": [
                      "3595c308-5a07-4aa7-9d6c-42ddc8160ffd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "eb72f97b-a360-400c-9da0-1608dfe28110",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "c430f20e-c4cd-42e4-b3c4-be40fc3017a9",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "e7476656-da24-4772-ac77-d6944e2236ca",
                    "activityIds": [
                      "7c0b8a96-aa0f-4298-90fd-2e90d232642a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "771541ee-7316-4065-93e1-8b522a2ee885",
                    "activityIds": [
                      "8543a0bb-a714-439c-80ea-f76167e60409"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "5601a8e2-0225-4ae2-93ae-133b92a43673",
                    "activityIds": [
                      "006885a1-00d8-4040-89d3-89470d0bb899"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "7f728494-260b-4eee-9b1d-db6c022a9a79",
                    "activityIds": [
                      "a7ccc6e4-18cb-4f88-adb6-2b3640940b97"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "4701e5e0-7d5b-4192-8066-b2424d2e930c",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "d2c6daee-1dcb-4dac-bb8d-12efc01d8695",
                    "activityIds": [
                      "9da125c3-d150-4d9e-8ef5-a1a477141c3b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "05d39beb-160d-4e9c-99a9-a0583f5f7462",
                    "activityIds": [
                      "f576043b-870d-4e75-a1b9-cf4b9906fea5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_2",
                    "encounterId": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54"
                  },
                  {
                    "id": "9c936f82-c4b9-4080-b56b-e6d66b051634",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "75cf2df0-cbab-4b77-a559-0aca8ad1e5bb",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "e856fe6b-a22f-4420-9213-b2b09af7e16e",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "e15ae6cb-6e86-405b-a528-65e6764d79af",
                    "activityIds": [
                      "7c0b8a96-aa0f-4298-90fd-2e90d232642a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "a8383119-8f76-425c-a9f6-05a9037be471",
                    "activityIds": [
                      "8543a0bb-a714-439c-80ea-f76167e60409"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "7553e710-499b-403b-af56-f3f35ef1837f",
                    "activityIds": [
                      "006885a1-00d8-4040-89d3-89470d0bb899"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "fffc85ca-5a14-470a-b4b3-b53d290bac48",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "c9eb97b9-eca1-42a5-8ce2-004f088eb8c0",
                    "activityIds": [
                      "9da125c3-d150-4d9e-8ef5-a1a477141c3b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "c50e2378-10e2-4eba-bb64-64bd31e3c875",
                    "activityIds": [
                      "f576043b-870d-4e75-a1b9-cf4b9906fea5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_3",
                    "encounterId": "ee423ea8-8e78-445b-b604-18d658454270"
                  },
                  {
                    "id": "3ddd1e47-b88c-47ed-9f27-293dbdf13036",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "95b19d60-d6c5-4412-8bad-33a3b0b972bb",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "ce95c7d7-b045-4c86-8d56-f227712bb45c",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "8148d5a3-6f03-44c7-85c2-b5bfbcdfc32f",
                    "activityIds": [
                      "7c0b8a96-aa0f-4298-90fd-2e90d232642a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "fd489424-8ed6-4ac5-822b-9a314e78015f",
                    "activityIds": [
                      "8543a0bb-a714-439c-80ea-f76167e60409"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "172358bb-7c61-4f33-bc7f-5a6ce0871b7d",
                    "activityIds": [
                      "006885a1-00d8-4040-89d3-89470d0bb899"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "4696ad14-02dd-405c-9802-674443f7a243",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "cb61c5cc-6a06-4aed-b2ab-1c3ca1a22f7f",
                    "activityIds": [
                      "9da125c3-d150-4d9e-8ef5-a1a477141c3b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "635c1ee3-0111-481c-b2ca-3c24617ee707",
                    "activityIds": [
                      "f576043b-870d-4e75-a1b9-cf4b9906fea5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_4",
                    "encounterId": "f89fd58d-0957-49cf-8278-05509cf2d137"
                  },
                  {
                    "id": "d9363799-01e2-4504-9087-45ad4507fec7",
                    "activityIds": [
                      "982bea25-8062-4841-875d-c5dd72470734"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "cb37d063-6b3b-4a9e-abc6-ef0312d4492f",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "2cb1d4cb-929d-4fc9-aa1a-7c8ad340bb08",
                    "activityIds": [
                      "42ad366d-d32b-4dd8-9e6a-a11c846215d0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "b9f778b4-70f7-4eb2-82d6-8dfeb207b94e",
                    "activityIds": [
                      "40c255bc-3f8e-4d46-bd02-3bd545d99cfe"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "20e3c9b3-9253-4212-a9a8-b86b734219a3",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "d30f1430-64e7-4f95-9cae-670bee381971",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "e8db0d5c-53f6-450b-a494-32150c0ad09d",
                    "activityIds": [
                      "7c0b8a96-aa0f-4298-90fd-2e90d232642a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "e5c450ae-a9d6-4005-960a-2ec697ab2c58",
                    "activityIds": [
                      "8543a0bb-a714-439c-80ea-f76167e60409"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "d1d358ce-bd8a-4a29-a581-7bc96416ea9d",
                    "activityIds": [
                      "006885a1-00d8-4040-89d3-89470d0bb899"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "1f81ea9f-7a59-4e98-a36d-5800b3db886d",
                    "activityIds": [
                      "a7ccc6e4-18cb-4f88-adb6-2b3640940b97"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "3beb0d05-b45a-4185-a6fe-7987f69e04e5",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "3225f1ef-501c-414d-b749-74e37677b6b1",
                    "activityIds": [
                      "9da125c3-d150-4d9e-8ef5-a1a477141c3b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "58c55510-6301-4180-86f3-4f638ba86489",
                    "activityIds": [
                      "f576043b-870d-4e75-a1b9-cf4b9906fea5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_5",
                    "encounterId": "94bbad87-4f0b-4857-a3f2-8e8915706868"
                  },
                  {
                    "id": "b5cdf627-9a1f-4602-aebb-e8f940b196a9",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "a16262e7-9e30-4413-9422-c283c9615899",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "35c8d60e-8eb4-4189-93b2-59720d110195",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "34b7b42e-a295-430e-8c4e-6515854e90d0",
                    "activityIds": [
                      "7c0b8a96-aa0f-4298-90fd-2e90d232642a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "6b089d00-2d8e-48c2-bf21-cc91a7567ba6",
                    "activityIds": [
                      "8543a0bb-a714-439c-80ea-f76167e60409"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "298fc92a-b05d-4b16-92bd-e5913f8a6f79",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "6155bb75-eb1a-4c43-945a-733c54131349",
                    "activityIds": [
                      "9da125c3-d150-4d9e-8ef5-a1a477141c3b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "7b75c263-220a-47f6-94fe-7fc16394a0b1",
                    "activityIds": [
                      "f576043b-870d-4e75-a1b9-cf4b9906fea5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_6",
                    "encounterId": "e9e013e1-4716-454b-bab8-edcd1046de00"
                  },
                  {
                    "id": "464b0ba4-5a95-4a33-bc14-6dad1277fe78",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "bb21138d-2b9d-41c0-a9d4-f0fd7114b0ec",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "1ff25a6a-4f00-408c-b9b9-4c0698f547a8",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "9825d727-bfb7-4f14-ab24-82a5665058c6",
                    "activityIds": [
                      "7c0b8a96-aa0f-4298-90fd-2e90d232642a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "777b14e9-ef2a-43f8-9723-62d9f1c150be",
                    "activityIds": [
                      "8543a0bb-a714-439c-80ea-f76167e60409"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "f2feaa84-342c-46d8-8cfc-cd78cee7ac4a",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "0a5fcc32-def3-4ae2-ad4d-0baaa5b5cc52",
                    "activityIds": [
                      "9da125c3-d150-4d9e-8ef5-a1a477141c3b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "5b1345fd-3c2c-45ef-9aba-1e711b77626e",
                    "activityIds": [
                      "f576043b-870d-4e75-a1b9-cf4b9906fea5"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_25@enc_7",
                    "encounterId": "24f304d1-740b-4bcb-9d9f-1c696b169884"
                  },
                  {
                    "id": "1e47c607-81f5-4d37-ae58-daaae5ad0a2e",
                    "activityIds": [
                      "9774fdde-ba25-4f3f-9d85-6d54bad59551"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_8",
                    "encounterId": "d5d0919c-fbee-486b-803a-8d2f67029441"
                  },
                  {
                    "id": "385d17dc-68e2-4afa-8267-110de8135e8d",
                    "activityIds": [
                      "982bea25-8062-4841-875d-c5dd72470734"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "a34847c1-921b-46d4-92e2-c8f8ff3e742b",
                    "activityIds": [
                      "e722954a-af9c-4b73-8e7c-3be6462c9065"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "b7d60d49-0c63-4d5f-aa35-d3029b755f53",
                    "activityIds": [
                      "42ad366d-d32b-4dd8-9e6a-a11c846215d0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "c719592e-a554-4540-a254-d9192180a34d",
                    "activityIds": [
                      "40c255bc-3f8e-4d46-bd02-3bd545d99cfe"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "0004b21f-da37-4847-9bc7-c4eba2880af7",
                    "activityIds": [
                      "3595c308-5a07-4aa7-9d6c-42ddc8160ffd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "7666c7a0-0052-4db9-8b46-ad6f7ddeadaa",
                    "activityIds": [
                      "d3862527-2376-4c2e-b3bb-cf692cf5abfc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "86be5f2a-cda5-4cd8-90e2-a20ac975341d",
                    "activityIds": [
                      "ce49c80f-aba6-4b03-9b75-476baf785fac"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "b71bbe97-3626-4db7-a442-04a8d91d4230",
                    "activityIds": [
                      "6e112783-383a-4d3b-9b33-78ae4f35cb89"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "69e84c1b-50cb-437f-ab5e-91e10c1bd492",
                    "activityIds": [
                      "006885a1-00d8-4040-89d3-89470d0bb899"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "2a81d80d-505b-490d-b1ba-af03e0c89356",
                    "activityIds": [
                      "a7ccc6e4-18cb-4f88-adb6-2b3640940b97"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_22@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "3118a4a8-feee-4652-b820-b7d5a5fd9327",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "9fca9b33-b65f-41a6-8f09-7a5985d5768e",
                    "activityIds": [
                      "9da125c3-d150-4d9e-8ef5-a1a477141c3b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_24@enc_9",
                    "encounterId": "f334157a-0530-4c52-a7df-cb3effc65950"
                  },
                  {
                    "id": "f1c5d62d-88ce-4750-9940-e045e2a64eb3",
                    "activityIds": [
                      "9774fdde-ba25-4f3f-9d85-6d54bad59551"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_10",
                    "encounterId": "9881c4c3-d774-49c5-83b2-0f23cd10e656"
                  },
                  {
                    "id": "a24feeea-7b95-4fd4-ad95-055adcac0361",
                    "activityIds": [
                      "db121d6e-d24b-4185-a67d-fde88a22a31d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_23@enc_11",
                    "encounterId": "56427744-b3d8-445d-ac34-cd889a37fb02"
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "d6f1f0cc-e685-4dc9-b8cb-f9322c79c46e",
                "name": "Screening (28 days prior to C1D1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "2fb356b4-6c40-4cf5-a9ef-5bccf1881c47",
                  "code": "C48262",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening",
                  "instanceType": "Code"
                },
                "epochId": "0aa62bb4-7859-4cc0-9d38-928cd554c00c"
              },
              {
                "id": "468ca2f1-08d2-4e49-879f-d79dc3ef5d54",
                "name": "Cycle 1 Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "148355a7-f95c-4125-b5e5-83dc930ba49c",
                  "code": "C82517",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Baseline",
                  "instanceType": "Code"
                },
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53"
              },
              {
                "id": "ee423ea8-8e78-445b-b604-18d658454270",
                "name": "Cycle 1 Day 8",
                "instanceType": "Encounter",
                "type": {
                  "id": "d8c27296-4251-4fea-a12a-87c1854c6413",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53"
              },
              {
                "id": "f89fd58d-0957-49cf-8278-05509cf2d137",
                "name": "Cycle 1 Day 15",
                "instanceType": "Encounter",
                "type": {
                  "id": "12b38252-f64c-4f04-9dbf-04a1792f8bb9",
                  "code": "C82517",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Baseline",
                  "instanceType": "Code"
                },
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53"
              },
              {
                "id": "94bbad87-4f0b-4857-a3f2-8e8915706868",
                "name": "Cycle 2+ Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "409a7e44-42da-4d31-929d-63fb3c1b877a",
                  "code": "C82517",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Baseline",
                  "instanceType": "Code"
                },
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53"
              },
              {
                "id": "e9e013e1-4716-454b-bab8-edcd1046de00",
                "name": "Cycle 2+ Day 8",
                "instanceType": "Encounter",
                "type": {
                  "id": "cde8f24b-b80e-458f-b17b-187085525562",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53"
              },
              {
                "id": "24f304d1-740b-4bcb-9d9f-1c696b169884",
                "name": "Cycle 2+ Day 15",
                "instanceType": "Encounter",
                "type": {
                  "id": "abe1f7b2-893e-46e0-9fca-983a4ba31ac5",
                  "code": "C82517",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Baseline",
                  "instanceType": "Code"
                },
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53"
              },
              {
                "id": "d5d0919c-fbee-486b-803a-8d2f67029441",
                "name": "Every 3 Cycles Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "b040aff5-e6d0-4b0e-b536-b9d6dc9f5b08",
                  "code": "C82517",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Baseline",
                  "instanceType": "Code"
                },
                "epochId": "42829394-85ae-4c4a-a83d-3c2272c23b53"
              },
              {
                "id": "f334157a-0530-4c52-a7df-cb3effc65950",
                "name": "30-day Follow-up",
                "instanceType": "Encounter",
                "type": {
                  "id": "b2064975-ed57-4778-a998-4522b36dbd35",
                  "code": "C99158",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up",
                  "instanceType": "Code"
                },
                "epochId": "b3753bb6-f9e7-4fa0-9eed-78cff39dac4c"
              },
              {
                "id": "9881c4c3-d774-49c5-83b2-0f23cd10e656",
                "name": "Every 8 Weeks",
                "instanceType": "Encounter",
                "type": {
                  "id": "c7a456e3-7938-45f6-bcc5-a947425bbb35",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "1dd184b2-68a4-41b5-a361-7392611604ff"
              },
              {
                "id": "56427744-b3d8-445d-ac34-cd889a37fb02",
                "name": "Survival Follow-up",
                "instanceType": "Encounter",
                "type": {
                  "id": "6d1155ec-7ea3-4f37-bf44-b08354746298",
                  "code": "C99158",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up",
                  "instanceType": "Code"
                },
                "epochId": "1dd184b2-68a4-41b5-a361-7392611604ff"
              }
            ],
            "activities": [
              {
                "id": "bcdc3a2f-b131-4984-a6db-20966fc6ff32",
                "name": "Study Procedures",
                "instanceType": "Activity",
                "childIds": [
                  "42cdc236-991b-41ee-bcd0-fb0cb85a886a",
                  "68cfdab1-0110-4d56-a05b-b061351413a4",
                  "215b3c94-0fd3-4b58-a4a1-3f18ee485886",
                  "982bea25-8062-4841-875d-c5dd72470734",
                  "e722954a-af9c-4b73-8e7c-3be6462c9065",
                  "42ad366d-d32b-4dd8-9e6a-a11c846215d0",
                  "6da409cd-1281-49ea-907b-4a8bc20edba4",
                  "40c255bc-3f8e-4d46-bd02-3bd545d99cfe",
                  "3595c308-5a07-4aa7-9d6c-42ddc8160ffd"
                ]
              },
              {
                "id": "41a86a27-9f65-41ca-a3a6-8ad647afca68",
                "name": "Laboratory Assessments",
                "instanceType": "Activity",
                "childIds": [
                  "d3862527-2376-4c2e-b3bb-cf692cf5abfc",
                  "ce49c80f-aba6-4b03-9b75-476baf785fac",
                  "f3394c48-9f98-41b4-85d6-dc6685a47cec",
                  "6e112783-383a-4d3b-9b33-78ae4f35cb89",
                  "f8ca4e3d-b60e-4469-86bf-701b5568dd1d",
                  "735813c5-f0f1-4a58-b4f3-ef163b82ba52",
                  "2bfcac8b-af85-4da1-8ead-fa245c0b87fc"
                ]
              },
              {
                "id": "aa7f672e-19d3-4850-8c52-4887158615b7",
                "name": "Tumor Assessments",
                "instanceType": "Activity",
                "childIds": [
                  "9774fdde-ba25-4f3f-9d85-6d54bad59551",
                  "1a3724e2-fb57-41b1-a2ac-a5d7a956c4b8"
                ]
              },
              {
                "id": "3f95bc7d-e435-425d-b908-bfbc58286cb3",
                "name": "Study Drug Administration",
                "instanceType": "Activity",
                "childIds": [
                  "7c0b8a96-aa0f-4298-90fd-2e90d232642a",
                  "8543a0bb-a714-439c-80ea-f76167e60409"
                ]
              },
              {
                "id": "3b62838c-666d-47d8-8c1f-2717307e75a6",
                "name": "Pharmacokinetic Assessments",
                "instanceType": "Activity",
                "childIds": [
                  "006885a1-00d8-4040-89d3-89470d0bb899",
                  "a7ccc6e4-18cb-4f88-adb6-2b3640940b97"
                ]
              },
              {
                "id": "17be8aaa-5c22-48ad-8267-ef996156037b",
                "name": "Safety Monitoring",
                "instanceType": "Activity",
                "childIds": [
                  "db121d6e-d24b-4185-a67d-fde88a22a31d",
                  "9da125c3-d150-4d9e-8ef5-a1a477141c3b",
                  "f576043b-870d-4e75-a1b9-cf4b9906fea5"
                ]
              },
              {
                "id": "42cdc236-991b-41ee-bcd0-fb0cb85a886a",
                "name": "Informed Consent",
                "instanceType": "Activity",
                "description": "Obtain written informed consent from participant"
              },
              {
                "id": "68cfdab1-0110-4d56-a05b-b061351413a4",
                "name": "Demographics",
                "instanceType": "Activity",
                "description": "Collect participant demographic information"
              },
              {
                "id": "215b3c94-0fd3-4b58-a4a1-3f18ee485886",
                "name": "Medical History",
                "instanceType": "Activity",
                "description": "Collect participant medical history"
              },
              {
                "id": "982bea25-8062-4841-875d-c5dd72470734",
                "name": "Physical Examination",
                "instanceType": "Activity",
                "description": "Complete physical examination"
              },
              {
                "id": "e722954a-af9c-4b73-8e7c-3be6462c9065",
                "name": "Vital Signs",
                "instanceType": "Activity",
                "description": "Measure vital signs"
              },
              {
                "id": "42ad366d-d32b-4dd8-9e6a-a11c846215d0",
                "name": "ECOG Performance Status",
                "instanceType": "Activity",
                "description": "Assess ECOG performance status"
              },
              {
                "id": "6da409cd-1281-49ea-907b-4a8bc20edba4",
                "name": "Height",
                "instanceType": "Activity",
                "description": "Measure participant height"
              },
              {
                "id": "40c255bc-3f8e-4d46-bd02-3bd545d99cfe",
                "name": "Weight",
                "instanceType": "Activity",
                "description": "Measure participant weight"
              },
              {
                "id": "3595c308-5a07-4aa7-9d6c-42ddc8160ffd",
                "name": "12-lead ECG",
                "instanceType": "Activity",
                "description": "Perform 12-lead electrocardiogram"
              },
              {
                "id": "d3862527-2376-4c2e-b3bb-cf692cf5abfc",
                "name": "Hematology",
                "instanceType": "Activity",
                "description": "Hematology laboratory assessment"
              },
              {
                "id": "ce49c80f-aba6-4b03-9b75-476baf785fac",
                "name": "Serum Chemistry",
                "instanceType": "Activity",
                "description": "Serum chemistry laboratory assessment including ALT, AST, total bilirubin"
              },
              {
                "id": "f3394c48-9f98-41b4-85d6-dc6685a47cec",
                "name": "Coagulation",
                "instanceType": "Activity",
                "description": "Coagulation laboratory assessment including PT-INR"
              },
              {
                "id": "6e112783-383a-4d3b-9b33-78ae4f35cb89",
                "name": "Urinalysis",
                "instanceType": "Activity",
                "description": "Urinalysis laboratory assessment"
              },
              {
                "id": "f8ca4e3d-b60e-4469-86bf-701b5568dd1d",
                "name": "Pregnancy Test",
                "instanceType": "Activity",
                "description": "Pregnancy test for women of childbearing potential"
              },
              {
                "id": "735813c5-f0f1-4a58-b4f3-ef163b82ba52",
                "name": "Hepatitis B/C and HIV Testing",
                "instanceType": "Activity",
                "description": "Serological tests for viral hepatitis A, B, C, E and HIV"
              },
              {
                "id": "2bfcac8b-af85-4da1-8ead-fa245c0b87fc",
                "name": "Thyroid Function Tests",
                "instanceType": "Activity",
                "description": "Thyroid function laboratory assessment"
              },
              {
                "id": "9774fdde-ba25-4f3f-9d85-6d54bad59551",
                "name": "CT/MRI Scan",
                "instanceType": "Activity",
                "description": "Computed tomography or MRI scan for tumor assessment per RECIST 1.1"
              },
              {
                "id": "1a3724e2-fb57-41b1-a2ac-a5d7a956c4b8",
                "name": "Tumor Biopsy",
                "instanceType": "Activity",
                "description": "Tumor biopsy for assessment"
              },
              {
                "id": "7c0b8a96-aa0f-4298-90fd-2e90d232642a",
                "name": "Ramucirumab SC Administration",
                "instanceType": "Activity",
                "description": "Subcutaneous ramucirumab administration with loading dose and maintenance dose regimen"
              },
              {
                "id": "8543a0bb-a714-439c-80ea-f76167e60409",
                "name": "Combination Therapy Administration",
                "instanceType": "Activity",
                "description": "Administration of combination therapy (paclitaxel, FOLFIRI, erlotinib, or docetaxel)"
              },
              {
                "id": "006885a1-00d8-4040-89d3-89470d0bb899",
                "name": "PK Blood Sampling",
                "instanceType": "Activity",
                "description": "Pharmacokinetic blood sampling for ramucirumab concentration analysis"
              },
              {
                "id": "a7ccc6e4-18cb-4f88-adb6-2b3640940b97",
                "name": "Immunogenicity Sampling",
                "instanceType": "Activity",
                "description": "Blood sampling for immunogenicity assessment"
              },
              {
                "id": "db121d6e-d24b-4185-a67d-fde88a22a31d",
                "name": "Adverse Events",
                "instanceType": "Activity",
                "description": "Adverse event assessment and documentation"
              },
              {
                "id": "9da125c3-d150-4d9e-8ef5-a1a477141c3b",
                "name": "Concomitant Medications",
                "instanceType": "Activity",
                "description": "Review and documentation of concomitant medications"
              },
              {
                "id": "f576043b-870d-4e75-a1b9-cf4b9906fea5",
                "name": "Injection Site Reactions",
                "instanceType": "Activity",
                "description": "Assessment of injection site reactions"
              }
            ],
            "epochs": [
              {
                "id": "0aa62bb4-7859-4cc0-9d38-928cd554c00c",
                "name": "Screening",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "25821f11-f087-49b2-a1de-143eec9d89c5",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "42829394-85ae-4c4a-a83d-3c2272c23b53",
                "name": "Treatment Period",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "b7a990ab-92da-4d33-97ab-15109e366b36",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "b3753bb6-f9e7-4fa0-9eed-78cff39dac4c",
                "name": "Short-term Follow-up",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "1cf164d8-d057-46c1-94c3-330c481c7047",
                  "code": "C98781",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "1dd184b2-68a4-41b5-a361-7392611604ff",
                "name": "Long-term Follow-up",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "c55662ec-59c3-48fb-9b7e-e6fb0de83b48",
                  "code": "C98781",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Epoch",
                  "instanceType": "Code"
                }
              }
            ],
            "notes": [
              {
                "id": "074dc2c7-b9cf-4dd9-8439-13c49468bd59",
                "text": "a. In Sub-Cohort B1, the loading dose will not be given",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d9a101f8-9c1c-452f-8cf8-20387fe9fca9",
                "text": "b. MD: Weekly dosing starting on Week 2 (Cycle 1 Day 8) except for B1 when it will be starting on Week 1 (Cycle 1, Day 1)",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "78bb2875-0bd8-4ab0-a8d9-9e8af2e27e13",
                "text": "c. Only 1 dosing regimen (one LD - MD level) will be investigated in Sub-Cohort B2 and Sub-Cohort B3. Dose will be selected based on PK and safety data",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "02a949c0-5554-47e7-933a-1c2fc0676f05",
                "text": "LD = loading dose; MD = maintenance dose; QW = every week; SC = subcutaneous; Q2W = every 2 weeks",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d9673ed3-bac0-4b6f-8df7-144fb8bafb62",
                "text": "AUC = area under the plasma concentration versus time curve; eq = equivalent; F = bioavailability; IV = intravenous",
                "instanceType": "CommentAnnotation"
              }
            ],
            "model": {
              "id": "a9412f0b-3376-45d1-a445-4bd39278c88a",
              "code": "C82639",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Parallel Study",
              "instanceType": "Code"
            }
          }
        ],
        "titles": [
          {
            "id": "2a6d5e6e-2681-4109-8950-152531f5982f",
            "text": "A Phase 1, Nonrandomized, Open-Label Investigation of Subcutaneous Ramucirumab Administration in Participants with Advanced Solid Tumors",
            "type": {
              "id": "0cd18e8f-1460-4164-81ae-15874d6ed25b",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "84f477ef-ccd4-4c6b-9904-edb63a8b528f",
            "text": "A Phase 1 Investigation of Subcutaneous Ramucirumab Administration in Participants with Advanced Solid Tumors",
            "type": {
              "id": "ae8672ff-aa8e-45c2-8d16-174bdc3d989d",
              "code": "Brief Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Brief Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "93312db7-8c7e-4a50-b4f6-b8067d89699a",
            "text": "NCT04557384",
            "instanceType": "StudyIdentifier",
            "scopeId": "2a33e67c-d5c3-4728-8a13-c883283be394",
            "type": {
              "code": "C172240",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinicaltrials.gov Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "be2b7bbf-fd86-42c5-a8b7-9a05c44617c0",
            "text": "I4T-MC-JVDU",
            "instanceType": "StudyIdentifier",
            "scopeId": "2a33e67c-d5c3-4728-8a13-c883283be394",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "d454fd63-e27f-4584-8ef0-b7a41e47289b",
            "text": "IND: 148078",
            "instanceType": "StudyIdentifier",
            "scopeId": "2a33e67c-d5c3-4728-8a13-c883283be394",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "studyPhase": {
          "id": "c0845611-69ac-4c2c-8537-677f7f45e94d",
          "code": "Phase1",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase1",
          "instanceType": "Code"
        },
        "rationale": "Protocol version"
      }
    ],
    "organizations": [
      {
        "id": "98a7ff8f-b3df-4e46-8e2f-874161dc20f9",
        "name": "Eli Lilly and Company",
        "type": {
          "id": "7247ead0-885d-4892-be06-7460f3a54f21",
          "code": "Pharmaceutical Company",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Pharmaceutical Company",
          "instanceType": "Code"
        },
        "instanceType": "Organization"
      }
    ],
    "indications": [
      {
        "id": "a4fc6633-d0d0-4f58-8b17-6417ae4170a9",
        "name": "Advanced Solid Tumors",
        "isRareDisease": false,
        "instanceType": "Indication",
        "description": "Participants with Advanced Solid Tumors"
      }
    ],
    "name": "A Phase 1, Nonrandomized, Open-Label Investigation of Subcutaneous Ramucirumab Administration in Participants with Advanced Solid Tumors"
  },
  "administrableProducts": [
    {
      "id": "e9962bcd-1fc8-4854-ad4a-d09611395036",
      "name": "Ramucirumab SC",
      "instanceType": "AdministrableProduct",
      "doseForm": {
        "id": "49ed4f95-c78a-4d53-b770-78010a13d70a",
        "code": "Solution",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Solution",
        "instanceType": "Code"
      },
      "strength": "Various (350 mg, 700 mg, 875 mg, 1750 mg)",
      "substanceIds": [
        "55897021-a26c-4c5e-af4e-d8aaad4c8180"
      ],
      "manufacturer": "Eli Lilly"
    }
  ],
  "administrations": [
    {
      "id": "81c6fb19-438e-47c9-a033-6f957d3f3cd5",
      "name": "Cohort A - Loading Dose",
      "instanceType": "Administration",
      "dose": "700 mg",
      "doseFrequency": "Once (Day 1)",
      "route": {
        "id": "2465f7eb-6afa-4a5c-bc26-7efbbb7d1c71",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Single dose"
    },
    {
      "id": "8cab917b-7dad-47df-a0d3-96c85077175a",
      "name": "Cohort A - Maintenance Dose",
      "instanceType": "Administration",
      "dose": "350 mg",
      "doseFrequency": "Once weekly (QW)",
      "route": {
        "id": "1bc9aa23-91fe-481b-9430-a590e97317a6",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Until disease progression or discontinuation"
    },
    {
      "id": "d3e64b5b-a0b3-4fcc-8aec-01d79f8a032a",
      "name": "Sub-Cohort B1 - Maintenance Dose",
      "instanceType": "Administration",
      "dose": "875 mg",
      "doseFrequency": "Once weekly (QW)",
      "route": {
        "id": "e429ac05-be81-4bf7-a771-154058a087c3",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Starting Week 1, no loading dose"
    },
    {
      "id": "d96abadb-2c08-47e9-9b48-93b08d9ffcb6",
      "name": "Sub-Cohort B2 - Loading Dose",
      "instanceType": "Administration",
      "dose": "1750 mg (maximum)",
      "doseFrequency": "Once (Day 1)",
      "route": {
        "id": "ba6d6b79-231b-433b-99c1-a775e00bd56a",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Single dose via SC infusion pump at approximately 0.25 ml/min"
    },
    {
      "id": "5f8aeb39-9dff-4b3e-95b1-adfff8423c6e",
      "name": "Sub-Cohort B2 - Maintenance Dose",
      "instanceType": "Administration",
      "dose": "875 mg (maximum)",
      "doseFrequency": "Once weekly (QW)",
      "route": {
        "id": "ed548491-0dab-4556-b701-eb83adee68d0",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Starting Week 2 (Cycle 1 Day 8)"
    },
    {
      "id": "da320cdd-8f1a-4006-b995-6010094225ed",
      "name": "Sub-Cohort B3 - Loading Dose (Optional)",
      "instanceType": "Administration",
      "dose": "<1750 mg",
      "doseFrequency": "Once (Day 1)",
      "route": {
        "id": "259b4f3d-338c-435e-a4cb-32f53c0997f7",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Single dose, dose adjusted based on PK/safety data"
    },
    {
      "id": "e2815512-d211-4771-9066-951afeab5ef2",
      "name": "Sub-Cohort B3 - Maintenance Dose (Optional)",
      "instanceType": "Administration",
      "dose": "<875 mg",
      "doseFrequency": "Once weekly (QW)",
      "route": {
        "id": "558ba56b-2183-470e-bc57-8b79372f2e34",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Dose adjusted based on PK/safety data"
    },
    {
      "id": "63fcb27d-7637-4462-9e3f-39e8ad5f5d3b",
      "name": "Cohort C - Dosing Regimen",
      "instanceType": "Administration",
      "dose": "Same as Cohort B (determined by PK/safety objectives)",
      "doseFrequency": "Once weekly (QW) with loading dose",
      "route": {
        "id": "9cfaa8a9-eb8d-4321-b929-93899158a029",
        "code": "Subcutaneous",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous",
        "instanceType": "Code"
      },
      "duration": "Until disease progression or discontinuation"
    }
  ],
  "substances": [
    {
      "id": "55897021-a26c-4c5e-af4e-d8aaad4c8180",
      "name": "Ramucirumab",
      "instanceType": "Substance",
      "description": "Human receptor-targeted monoclonal antibody that specifically binds VEGF Receptor 2"
    }
  ],
  "narrativeContents": [
    {
      "id": "6ddae70c-186e-4217-86ab-2a7ef2016b68",
      "name": "Protocol Summary",
      "order": 0,
      "instanceType": "NarrativeContent",
      "sectionNumber": "1",
      "sectionTitle": "Protocol Summary",
      "sectionType": {
        "id": "6511b050-9df3-4a18-9f31-35c8e2d8efa3",
        "code": "Synopsis",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Synopsis",
        "instanceType": "Code"
      },
      "childIds": [
        "015a18b0-7139-49cd-9245-46379717d110",
        "a969b2c5-e7b9-4432-8871-a1ceb9f9abd4",
        "274da3ff-9531-43da-8998-05b429e6fc90",
        "d92b54b4-f94a-4f83-8e92-1f3b39a04cbe"
      ]
    },
    {
      "id": "f7ac557f-569b-4044-b92e-4fcbf7a155c1",
      "name": "Introduction",
      "order": 1,
      "instanceType": "NarrativeContent",
      "sectionNumber": "2",
      "sectionTitle": "Introduction",
      "sectionType": {
        "id": "9aecce69-29b1-4728-b72c-e8f8f251d8fc",
        "code": "Introduction",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Introduction",
        "instanceType": "Code"
      },
      "childIds": [
        "03f89e75-2204-4f29-823e-e4e2b588b54d",
        "97caee21-68e3-465d-9d8c-1510aa66e642",
        "327ba49b-0e01-4166-88a7-c6506a792948",
        "a22a6cda-9ade-4161-834d-0389e2d82ef6",
        "37c9c7fc-c51f-4a26-9871-092fa47eb814",
        "a0044321-9efd-4bbc-81be-7ed2550ba44d"
      ]
    },
    {
      "id": "e296f2c9-1e18-4664-990d-ce756427a60d",
      "name": "Objectives and Endpoints",
      "order": 2,
      "instanceType": "NarrativeContent",
      "sectionNumber": "3",
      "sectionTitle": "Objectives and Endpoints",
      "sectionType": {
        "id": "796a4b7a-faf3-4727-b3ce-e7eba20d0b06",
        "code": "Objectives",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Objectives",
        "instanceType": "Code"
      }
    },
    {
      "id": "8923ff04-0014-46b2-85f3-244c54d7a6a6",
      "name": "Study Design",
      "order": 3,
      "instanceType": "NarrativeContent",
      "sectionNumber": "4",
      "sectionTitle": "Study Design",
      "sectionType": {
        "id": "06a9296e-b66c-417e-ab05-47f94e28b6b8",
        "code": "Study Design",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Study Design",
        "instanceType": "Code"
      },
      "childIds": [
        "ad2d5013-a601-4e45-b2c4-fa310f518735",
        "5773c29a-2ad3-4327-91ea-82b41b96ff2e",
        "f518ff7e-23bc-4622-a793-d4a6c9d2d3bf",
        "63ee8f64-0f6b-4283-a6a6-c70280c67fa0",
        "8db1914a-adb3-4772-a173-1378898f3e90",
        "3117db7a-56fb-4088-a9f3-024090039e52",
        "346382f5-eddf-4b51-8534-6dd2409df69d",
        "547285e2-abd8-492a-acb4-39f516946e8d",
        "22e15432-38a6-430b-92ea-93087fdc4dd6",
        "2b397d82-4129-4e28-abd0-1ee5d9eb2fa5",
        "3331f149-d283-4969-a304-05c313dae3da",
        "108037c7-6686-4bf7-a4e3-8116ff275755",
        "ee757908-f02b-4f93-a66d-0bfa2eb7a17f"
      ]
    },
    {
      "id": "d2b84156-ecf0-4e8a-aa9c-42a3c161b2b2",
      "name": "Study Population",
      "order": 4,
      "instanceType": "NarrativeContent",
      "sectionNumber": "5",
      "sectionTitle": "Study Population",
      "sectionType": {
        "id": "0b3ce3ce-3f30-49f6-89fc-3bc0947de2c9",
        "code": "Study Population",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Study Population",
        "instanceType": "Code"
      },
      "childIds": [
        "45e2e611-45cd-4e28-8e84-2377072667e3",
        "d45a4ee1-9bed-4e10-b84c-a287df6c2810",
        "ea5479cb-f093-46b2-9c2a-f5fe629957d8",
        "464f9a13-5a75-4354-a4d9-1e6ea82330d0"
      ]
    },
    {
      "id": "95c8471e-e498-4778-b020-3bbca89cc7bd",
      "name": "Study Intervention",
      "order": 5,
      "instanceType": "NarrativeContent",
      "sectionNumber": "6",
      "sectionTitle": "Study Intervention",
      "sectionType": {
        "id": "91f73d0a-cfcc-4b7a-b694-cc81e6c73c5a",
        "code": "Treatment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Treatment",
        "instanceType": "Code"
      },
      "childIds": [
        "74a1e695-978c-4ae6-b9d6-1170c9672b90",
        "bee87a22-f622-4731-b35a-e267b84d978a",
        "4fd0c244-88b1-483f-867b-12e9711e4f64",
        "ba64bf7b-2d01-451c-b5bd-6176181d9ecb"
      ]
    }
  ],
  "abbreviations": [
    {
      "id": "411053c6-5be3-4d52-bc81-3cbaf5510c99",
      "abbreviatedText": "SC",
      "expandedText": "Subcutaneous",
      "instanceType": "Abbreviation"
    },
    {
      "id": "b01d77ff-6455-4ed9-a7f3-c2e38e92d6e5",
      "abbreviatedText": "IV",
      "expandedText": "Intravenous",
      "instanceType": "Abbreviation"
    },
    {
      "id": "c5d4e6b4-1f52-4db7-867f-779c79cc3a65",
      "abbreviatedText": "PK",
      "expandedText": "Pharmacokinetic",
      "instanceType": "Abbreviation"
    },
    {
      "id": "bfa1aadf-3205-4e91-8bd6-2b0fb5355292",
      "abbreviatedText": "SoA",
      "expandedText": "Schedule of Activities",
      "instanceType": "Abbreviation"
    },
    {
      "id": "f3741a54-eda3-47dd-9a30-f7d33e414b81",
      "abbreviatedText": "EC",
      "expandedText": "European Commission",
      "instanceType": "Abbreviation"
    }
  ],
  "studyDefinitionDocument": {
    "id": "a60dc96c-0ff9-403a-a83f-9cb4915162e3",
    "name": "Protocol I4T-MC-JVDU(e)",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "Amendment e",
    "versionDate": "2021-01-14",
    "contentIds": [
      "6ddae70c-186e-4217-86ab-2a7ef2016b68",
      "f7ac557f-569b-4044-b92e-4fcbf7a155c1",
      "e296f2c9-1e18-4664-990d-ce756427a60d",
      "8923ff04-0014-46b2-85f3-244c54d7a6a6",
      "d2b84156-ecf0-4e8a-aa9c-42a3c161b2b2",
      "95c8471e-e498-4778-b020-3bbca89cc7bd"
    ]
  },
  "studyAmendments": [
    {
      "id": "7025f8ca-0d2d-4541-a2df-ac8a2dbc8cfa",
      "number": "a",
      "scope": {
        "id": "1d7da2b7-c9a0-48e1-8b0f-a7f4c76170cc",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The overall rationale for the amendment is to provide clarifications in the protocol related to schedule of activities, administration of the investigational product namely subcutaneous (SC) ramucirumab and chemotherapy (FOLFIRI) as discussed below. There are no changes in the study-design, inclusion/exclusion criteria, or statistical analysis that would impact participant safety and overall objectives of the study.",
      "effectiveDate": "2020-09-14",
      "reasonIds": [
        "4fd3b3c5-1877-4b4f-9343-e8dc036c0e46",
        "bb343942-44bc-4cbf-b3eb-5364768ee30d"
      ],
      "previousVersion": "Original Protocol",
      "newVersion": "a"
    },
    {
      "id": "a724b49d-1424-4651-a463-c392979bee80",
      "number": "b",
      "scope": {
        "id": "3773b800-2d32-407a-9339-a376636d8177",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The overall rationale for the amendment is to incorporate changes and provide additional clarifications according to regulatory agency interactions.",
      "effectiveDate": "2020-10-02",
      "reasonIds": [
        "3a807fe2-3b48-4fe6-bc47-3d9435d2d865"
      ],
      "previousVersion": "a",
      "newVersion": "b"
    },
    {
      "id": "1b685aa2-81a0-48a4-b918-311896547c24",
      "number": "c",
      "scope": {
        "id": "c0ed1e67-740b-45eb-b982-575c272ead48",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The overall rationale for the amendment is to incorporate updates for hepatic safety and to allow participants to adjust their weekly maintenance dose to the maintenance dose of Cohort C once the dose has been confirmed.",
      "effectiveDate": "2020-11-05",
      "reasonIds": [
        "efb7ce86-8d21-45bc-800c-ac448c4ba747",
        "b788f528-1ffd-40da-b1b1-6b3763114e9f"
      ],
      "previousVersion": "b",
      "newVersion": "c"
    },
    {
      "id": "4ea108ba-015b-434b-992f-3d0b8350d7de",
      "number": "d",
      "scope": {
        "id": "41d82542-31ad-4b28-8634-42910335d966",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The overall rationale for the amendment is to make changes based on preliminary data from Study JVDT, to remove hepatocellular carcinoma (HCC) and gastric cancer patients from inclusion in Cohort A and add to Cohorts B and C, and to correct an error in the contraceptive language.",
      "effectiveDate": "2021-01-14",
      "reasonIds": [
        "bd7dbd20-91ad-47cd-93c1-14b9b0e67c8f",
        "fd33dade-19cf-48d0-8dab-00012a844005",
        "7bd48be8-3a1c-4847-a8a7-f1066c4057bc"
      ],
      "previousVersion": "c",
      "newVersion": "d"
    },
    {
      "id": "0d70e0d7-cd98-4fcc-aa51-e371f29f29a9",
      "number": "e",
      "scope": {
        "id": "85fea360-29e5-4444-89b2-63bed225a93a",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The overall rationale for the amendment is to enable investigation of additional dosage regimens. Preliminary interim analysis data from Study I4T-MC-JVDT, a single-site study in healthy participants who received a single dose of SC or IV ramucirumab indicated a 40% bioavailability for ramucirumab following SC administration (bioavailability previously predicted: >50%). A Sub-Cohort B1 has been added to provide a second-dose level (in addition to cohort A), with the goal to generate PK data from at least 6 participants to inform dosing strategy for Sub-Cohort B2 (loading dose and maintenance weekly dose).",
      "effectiveDate": "2021-02-26",
      "reasonIds": [
        "bef4b651-0dce-4489-af74-12c8bea255ca",
        "62b5d9ff-95b0-4862-ac8e-0d5f4268c84f"
      ],
      "previousVersion": "d",
      "newVersion": "e"
    }
  ],
  "geographicScope": {
    "id": "51d3e8af-3e96-4ca7-958d-bfebd07df668",
    "name": "Study Geographic Scope",
    "scopeType": "National",
    "instanceType": "GeographicScope",
    "countryIds": [
      "1a4edf70-ce01-4011-b661-2e8e68f6bf4f"
    ],
    "regions": [
      "North America"
    ]
  },
  "countries": [
    {
      "id": "1a4edf70-ce01-4011-b661-2e8e68f6bf4f",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    }
  ],
  "procedures": [
    {
      "id": "99500e9e-4463-4888-80a1-7f5c0969dc37",
      "name": "Subcutaneous Injection",
      "instanceType": "Procedure",
      "label": "SC Injection",
      "description": "Subcutaneous administration of ramucirumab in the abdomen, thigh, or upper arms",
      "procedureType": {
        "id": "fdc1e1dc-17ae-4299-858c-fa79b187c4fc",
        "code": "Therapeutic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic",
        "instanceType": "Code"
      },
      "code": {
        "id": "fe80633e-46eb-4371-9bbe-eb53cc7932b9",
        "code": "96372",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic, prophylactic, or diagnostic injection, subcutaneous or intramuscular",
        "instanceType": "Code"
      }
    },
    {
      "id": "6d96fee2-943b-43d1-a385-7a9b25573285",
      "name": "Subcutaneous Infusion",
      "instanceType": "Procedure",
      "label": "SC Infusion",
      "description": "Subcutaneous infusion using SC infusion pump for loading doses greater than 700 mg at rate of approximately 0.25 ml/min",
      "procedureType": {
        "id": "3dc1211e-7e74-4f54-b838-78da11c90c4c",
        "code": "Therapeutic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic",
        "instanceType": "Code"
      },
      "code": {
        "id": "ac0dd26a-86b4-4127-8509-e8914f34e276",
        "code": "96369",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Subcutaneous infusion",
        "instanceType": "Code"
      }
    },
    {
      "id": "679d1402-84f6-4c02-9e5f-1c95c61f83d0",
      "name": "Intravenous Infusion",
      "instanceType": "Procedure",
      "label": "IV Infusion",
      "description": "Intravenous administration of ramucirumab",
      "procedureType": {
        "id": "d566dd84-4265-4248-8e46-ecec176a8be8",
        "code": "Therapeutic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic",
        "instanceType": "Code"
      },
      "code": {
        "id": "ce7149d8-f5df-4d8d-9ca1-2119cce56f47",
        "code": "96413",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Chemotherapy administration, intravenous infusion technique",
        "instanceType": "Code"
      }
    },
    {
      "id": "6ccf9758-9652-498c-abee-869f0ae681ae",
      "name": "Blood Sample Collection",
      "instanceType": "Procedure",
      "label": "Blood Draw",
      "description": "Collection of blood samples for pharmacokinetics, immunogenicity, and laboratory assessments",
      "procedureType": {
        "id": "26872bb8-3d1a-4cf8-ac9c-b258c65cd48f",
        "code": "Sample Collection",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Sample Collection",
        "instanceType": "Code"
      },
      "code": {
        "id": "66e4ccc3-c501-4f1d-8dff-227a8010ee06",
        "code": "36415",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Collection of venous blood by venipuncture",
        "instanceType": "Code"
      }
    },
    {
      "id": "8737b39e-0ad2-4c10-a02d-19284407dfca",
      "name": "Urine Sample Collection",
      "instanceType": "Procedure",
      "label": "Urine Collection",
      "description": "Collection of urine samples for hypersensitivity tests",
      "procedureType": {
        "id": "47359697-ed67-45e4-b8c5-d3e2980a98dd",
        "code": "Sample Collection",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Sample Collection",
        "instanceType": "Code"
      },
      "code": {
        "id": "98ee2cab-103d-43aa-af13-2d4dfac40205",
        "code": "81050",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Urinalysis",
        "instanceType": "Code"
      }
    },
    {
      "id": "e31dcede-f66f-4037-93bb-9cd0dbd3ead0",
      "name": "Blood Pressure Monitoring",
      "instanceType": "Procedure",
      "label": "BP Monitoring",
      "description": "Monitoring of blood pressure during therapy for hypertension assessment",
      "procedureType": {
        "id": "3d926985-5552-405b-a916-e43da88f84ef",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "8f35b3e7-660e-4aa5-9117-e9854e1ca2c8",
        "code": "99473",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Blood pressure monitoring",
        "instanceType": "Code"
      }
    },
    {
      "id": "fb18ceaa-298a-49f2-a156-3062b82a1b27",
      "name": "Injection Site Reaction Assessment",
      "instanceType": "Procedure",
      "label": "ISR Assessment",
      "description": "Evaluation of local reactions at injection sites for erythema, induration, pain, pruritus, and edema",
      "procedureType": {
        "id": "7c1a3f36-a607-474d-9bbc-dd0229846160",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "b959d661-22f6-467d-a1d7-5fcbcf530f41",
        "code": "99211",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Office or other outpatient visit evaluation",
        "instanceType": "Code"
      }
    },
    {
      "id": "57c05d38-aafc-4c5a-84e9-e9570097a47d",
      "name": "Injection Site Pain Assessment",
      "instanceType": "Procedure",
      "label": "Pain Assessment",
      "description": "Assessment of pain at injection site",
      "procedureType": {
        "id": "47352e4e-2ae4-4d2a-bc3d-10d44718a080",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "d6679711-7a55-493c-9819-8c5dbc93efe3",
        "code": "99211",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Office or other outpatient visit evaluation",
        "instanceType": "Code"
      }
    },
    {
      "id": "78262207-554e-49c7-a982-4936325f4100",
      "name": "Clinical Safety Laboratory Assessments",
      "instanceType": "Procedure",
      "label": "Safety Labs",
      "description": "Laboratory assessments including bilirubin, ALT, AST, ANC, and platelets",
      "procedureType": {
        "id": "27a04112-5420-48b3-abc0-c16a21f8d474",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "93840060-1712-496f-b608-9eafa383d8c1",
        "code": "80053",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Comprehensive metabolic panel",
        "instanceType": "Code"
      }
    },
    {
      "id": "aa048928-2357-48fe-bbb8-3c571267af66",
      "name": "Hepatic Safety Monitoring",
      "instanceType": "Procedure",
      "label": "Liver Monitoring",
      "description": "Monitoring of hepatic function including liver failure and liver injury assessment",
      "procedureType": {
        "id": "2af7e79d-a5e9-404a-927a-7e350fd912dd",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "263cf2c1-84d6-46b6-8c54-b93b30f64d74",
        "code": "80076",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Hepatic function panel",
        "instanceType": "Code"
      }
    },
    {
      "id": "4bbb185f-0155-42a9-8793-f76244ed947c",
      "name": "Hypersensitivity Reaction Monitoring",
      "instanceType": "Procedure",
      "label": "HSR Monitoring",
      "description": "Monitoring for hypersensitivity reactions including anaphylaxis during and after administration with 1-hour observation period",
      "procedureType": {
        "id": "77ee6d09-d9bd-4903-b338-4409c666147c",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "41b563f8-5446-4791-b431-5fb290b2b1b4",
        "code": "99211",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Office or other outpatient visit evaluation",
        "instanceType": "Code"
      }
    },
    {
      "id": "cd6bf2de-c3e7-4425-8804-461d11dc8731",
      "name": "Brain Imaging",
      "instanceType": "Procedure",
      "label": "MRI Brain",
      "description": "Magnetic resonance imaging for confirmation of posterior reversible encephalopathy syndrome diagnosis",
      "procedureType": {
        "id": "cd8e8dbb-d022-4880-9256-cac2d856e6b0",
        "code": "Imaging",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Imaging",
        "instanceType": "Code"
      },
      "code": {
        "id": "c354ad60-524e-438f-b6c1-d87a06890f04",
        "code": "70553",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "MRI brain with and without contrast",
        "instanceType": "Code"
      }
    },
    {
      "id": "9e2783a5-769d-4a62-ab0a-4a87aab276e3",
      "name": "Pharmacokinetic Assessment",
      "instanceType": "Procedure",
      "label": "PK Assessment",
      "description": "Assessment of ramucirumab serum concentration for pharmacokinetic analysis",
      "procedureType": {
        "id": "66ca40c9-92d1-4059-90ab-4acc0a20b694",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "2b6730b1-7865-45aa-bc43-6fb3fe780da1",
        "code": "80299",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Quantitation of therapeutic drug",
        "instanceType": "Code"
      }
    },
    {
      "id": "fcf8f13e-a4bc-487b-a136-27044af86de8",
      "name": "Immunogenicity Assessment",
      "instanceType": "Procedure",
      "label": "ADA Testing",
      "description": "Assessment of anti-ramucirumab antibody for immunogenicity evaluation",
      "procedureType": {
        "id": "7a425d31-a927-4364-b802-489cd6d41b29",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "c0ced745-440a-4be4-a855-937dc3fbdfb4",
        "code": "86255",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Fluorescent antibody screen",
        "instanceType": "Code"
      }
    },
    {
      "id": "7bc1f9ef-f4e6-43eb-9f3f-2b09a649461c",
      "name": "Red Blood Cell Transfusion",
      "instanceType": "Procedure",
      "label": "RBC Transfusion",
      "description": "Transfusion of red blood cells as supportive care",
      "procedureType": {
        "id": "2647e444-d77c-44a6-8590-b5ea0a8b02e7",
        "code": "Therapeutic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic",
        "instanceType": "Code"
      },
      "code": {
        "id": "2ec4206b-05f2-48a4-afb9-e33489ab7652",
        "code": "36430",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Transfusion, blood or blood components",
        "instanceType": "Code"
      }
    },
    {
      "id": "194fcd0c-f9fa-4425-a579-628fd021df55",
      "name": "Platelet Transfusion",
      "instanceType": "Procedure",
      "label": "Platelet Transfusion",
      "description": "Transfusion of platelets as supportive care",
      "procedureType": {
        "id": "d31b613e-42dc-44cb-88a7-897b6fb794a4",
        "code": "Therapeutic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic",
        "instanceType": "Code"
      },
      "code": {
        "id": "80c2f3fe-db91-47aa-bea6-c17500fa9196",
        "code": "36430",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Transfusion, blood or blood components",
        "instanceType": "Code"
      }
    },
    {
      "id": "6c20fab7-f739-47a6-808f-5b7caa33f027",
      "name": "Safety Surveillance",
      "instanceType": "Procedure",
      "label": "Safety Monitoring",
      "description": "Ongoing safety surveillance and monitoring throughout the study",
      "procedureType": {
        "id": "f66e5fcf-65de-41ce-8db2-0504058de561",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "4f00790e-95e8-4c99-9b0e-87ae0e27fbeb",
        "code": "99211",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Office or other outpatient visit evaluation",
        "instanceType": "Code"
      }
    }
  ],
  "medicalDevices": [
    {
      "id": "ac0a52d1-e2bd-4a12-9b07-4fab49b277ac",
      "name": "Subcutaneous Infusion Pump",
      "instanceType": "MedicalDevice",
      "label": "SC Infusion Pump",
      "description": "Infusion pump for subcutaneous administration of ramucirumab loading doses greater than 700 mg at rate of approximately 0.25 ml/min",
      "deviceType": {
        "id": "754ebb70-0dc2-42fb-a8e3-968ebdb054fa",
        "code": "Drug Delivery Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Drug Delivery Device",
        "instanceType": "Code"
      },
      "manufacturer": "Not specified",
      "modelNumber": "Not specified"
    },
    {
      "id": "3c064679-9393-4b5a-82e8-ce8a9e14b3cd",
      "name": "Resuscitation Equipment",
      "instanceType": "MedicalDevice",
      "label": "Emergency Resuscitation",
      "description": "Resuscitation equipment readily available during loading dose and maintenance SC injection for hypersensitivity reaction management",
      "deviceType": {
        "id": "c2f6838b-48c3-46d2-8e09-462a87485b85",
        "code": "Monitoring Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring Device",
        "instanceType": "Code"
      },
      "manufacturer": "Not specified",
      "modelNumber": "Not specified"
    }
  ],
  "ingredients": [
    {
      "id": "b348fe92-1178-43bc-b2e9-42bb4c49922a",
      "name": "Ramucirumab",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "3bb1c0b9-4cff-4818-b12d-fbe54be11767"
    },
    {
      "id": "0b5bafc3-8258-4b58-9f46-3ecb8e931596",
      "name": "Paclitaxel",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "2c37c2cc-8e05-4a7e-a713-1f15e9f50859"
    },
    {
      "id": "e40df0b7-f39c-44ee-ab86-5528db9ced2a",
      "name": "Docetaxel",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "bd06b3a2-1d8d-43fd-8c5f-a8da41ff76ee"
    },
    {
      "id": "0a0968e1-af4c-4641-8b38-c26e6004c91b",
      "name": "Erlotinib",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "e2c70423-c548-4667-9dc2-b5c5ad22bca9"
    },
    {
      "id": "5e046b37-4259-4b9c-9f1f-0ccd2d33af36",
      "name": "Irinotecan",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "90eec8c1-d01f-4eaf-84e9-8ee5e791ef5e"
    },
    {
      "id": "bb059a56-8d3c-467f-b275-4e25ada224b3",
      "name": "Leucovorin",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "8687e238-40e8-4206-8e8f-cf33224b908a"
    },
    {
      "id": "7b7d1102-7679-4b78-b235-d6d0a628f43f",
      "name": "Fluorouracil",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "f194b9b8-2332-45cf-99a7-c857e1b4b31e"
    },
    {
      "id": "1c7ae394-e5fe-495b-84bf-92e17cba2534",
      "name": "Erythropoietin",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "04124f99-adbe-4933-8b6f-006d79aef7e8"
    },
    {
      "id": "0965867b-2254-4304-8915-5025028305c6",
      "name": "Granulocyte-Colony Stimulating Factor",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "206e9388-42ff-4f30-92f6-18a92ba63152"
    },
    {
      "id": "b12dc57a-b370-429e-a2f3-e85371537b2f",
      "name": "Acetaminophen",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "e04b3166-8768-42b7-a257-ef0816c987f5"
    },
    {
      "id": "93f995c7-f688-4890-94c8-f72b88cca050",
      "name": "Antihistamines",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "cdacdc05-121c-409c-918d-1e57fd3e2151"
    }
  ],
  "strengths": [
    {
      "id": "fa4c262f-e73a-4063-b93a-99c26905bc88",
      "instanceType": "Strength",
      "value": 700,
      "unit": "mg",
      "numerator": {
        "value": 700,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "e8e9227f-1c8f-4cdf-b73b-856272f8b7bd",
      "instanceType": "Strength",
      "value": 350,
      "unit": "mg",
      "numerator": {
        "value": 350,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "69574efd-73cd-4527-b203-d3f4410a255a",
      "instanceType": "Strength",
      "value": 875,
      "unit": "mg",
      "numerator": {
        "value": 875,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "50fe1538-1a2a-4f06-9e57-8e2af3815467",
      "instanceType": "Strength",
      "value": 1750,
      "unit": "mg",
      "numerator": {
        "value": 1750,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "6e118fd2-9603-411f-ac18-cf4485d0b7fe",
      "instanceType": "Strength",
      "value": 1400,
      "unit": "mg",
      "numerator": {
        "value": 1400,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "9a0c64a6-7014-4ff3-8046-ec592d905337",
      "instanceType": "Strength",
      "value": 1120,
      "unit": "mg",
      "numerator": {
        "value": 1120,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "0ca2fd04-42b9-4fb8-a5e3-ba9a5e867e1b",
      "instanceType": "Strength",
      "value": 880,
      "unit": "mg",
      "numerator": {
        "value": 880,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "5f756f24-dcab-4708-aa80-95def52267f4",
      "instanceType": "Strength",
      "value": 560,
      "unit": "mg",
      "numerator": {
        "value": 560,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "2edb7084-f0b2-4142-ba03-15e5bff9e2af",
      "instanceType": "Strength",
      "value": 440,
      "unit": "mg",
      "numerator": {
        "value": 440,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "6f8d871b-88e3-416f-ad25-3252cd2673bb",
      "instanceType": "Strength",
      "value": 10,
      "unit": "mg/kg",
      "numerator": {
        "value": 10,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "kg"
      }
    },
    {
      "id": "0183e97d-2d03-4bf0-914a-f1ad0bab8d26",
      "instanceType": "Strength",
      "value": 13,
      "unit": "mg/kg",
      "numerator": {
        "value": 13,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "kg"
      }
    },
    {
      "id": "ef3b8c3d-2e90-49a3-9937-e163baa36c60",
      "instanceType": "Strength",
      "value": 20,
      "unit": "mg/kg",
      "numerator": {
        "value": 20,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "kg"
      }
    }
  ],
  "timings": [
    {
      "id": "5e00877c-f318-42bf-8c85-1f9c552d5c8b",
      "name": "Paclitaxel Cycle Start Interval",
      "type": "After",
      "unit": "days",
      "instanceType": "Timing",
      "value": 14,
      "relativeTo": "Previous Visit",
      "windowLower": -3,
      "windowUpper": 3
    },
    {
      "id": "622e06e7-84ac-4f3d-8fa4-2d774920cea9",
      "name": "FOLFIRI Cycle Start Interval",
      "type": "After",
      "unit": "days",
      "instanceType": "Timing",
      "value": 14,
      "relativeTo": "Previous Visit",
      "windowLower": -3,
      "windowUpper": 3
    },
    {
      "id": "2562c902-8422-4a59-8601-8710e732d223",
      "name": "Erlotinib Cycle Start Interval",
      "type": "After",
      "unit": "days",
      "instanceType": "Timing",
      "value": 7,
      "relativeTo": "Previous Visit",
      "windowLower": -3,
      "windowUpper": 3
    },
    {
      "id": "e14a5023-e0c6-4cf0-b382-37a84e1b9b28",
      "name": "Docetaxel Cycle Start Interval",
      "type": "After",
      "unit": "days",
      "instanceType": "Timing",
      "value": 21,
      "relativeTo": "Previous Visit",
      "windowLower": -3,
      "windowUpper": 3
    },
    {
      "id": "fbe505f0-3cd8-47f6-b860-d35118cf2627",
      "name": "Paclitaxel Cycle Duration",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 28,
      "relativeTo": "First Dose",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "72204213-5be8-4c38-b491-c216d9c03177",
      "name": "FOLFIRI Cycle Duration",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 28,
      "relativeTo": "First Dose",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "54196781-bfe1-4536-b3d6-7cdd737cc3e4",
      "name": "Erlotinib Cycle Duration",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 28,
      "relativeTo": "First Dose",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "395646ca-a242-40a9-a2bc-bf6c2a0e1303",
      "name": "Docetaxel Cycle Duration",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 21,
      "relativeTo": "First Dose",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "1b0fdf7c-4f99-4281-9c65-7460d8ac886e",
      "name": "Paclitaxel Administration Days",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 1,
      "relativeTo": "First Dose",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "6d35ff7b-6878-4da8-9beb-ae3f945c965f",
      "name": "NSAID Washout Period",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 7,
      "relativeTo": "First Dose",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "0c88cbc5-72f2-4b96-acf6-a3ae33984a04",
      "name": "Investigational Product Washout",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 30,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "c5858494-8f68-4cc8-97d3-8827d1db2166",
      "name": "GI Perforation/Fistula History Exclusion",
      "type": "Before",
      "unit": "months",
      "instanceType": "Timing",
      "value": 6,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "5ff9b2f6-294f-41d7-9dde-0ab3fe6d505f",
      "name": "Wound/Ulcer/Bone Fracture Exclusion",
      "type": "Before",
      "unit": "weeks",
      "instanceType": "Timing",
      "value": 4,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "682651b3-0cf3-4f95-ad29-d462d51eb868",
      "name": "Major Surgery Exclusion",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 28,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "e3f207e7-ae39-48ef-b1b8-017ff61340a4",
      "name": "Central Venous Access Device Placement",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 7,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "1e1be95a-8303-40eb-b1e1-642012793b17",
      "name": "Hemoptysis History Exclusion (NSCLC)",
      "type": "Before",
      "unit": "months",
      "instanceType": "Timing",
      "value": 2,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "f5e6afcf-3e1c-4419-aae4-623d6c9f5e88",
      "name": "CNS Metastases Stability Requirement",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 30,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "cd0182ed-a01e-463b-8045-106d34088f48",
      "name": "Rescreening Interval",
      "type": "After",
      "unit": "weeks",
      "instanceType": "Timing",
      "value": 2,
      "relativeTo": "Screening",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "3ca61754-fba7-4b6c-a5d8-ca96e8687b4e",
      "name": "Maximum Treatment Delay",
      "type": "Within",
      "unit": "weeks",
      "instanceType": "Timing",
      "value": 4,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 28
    },
    {
      "id": "62f7f542-fe5f-4be5-98f9-b3ce6fab5c95",
      "name": "Loading Dose Re-administration Threshold",
      "type": "After",
      "unit": "days",
      "instanceType": "Timing",
      "value": 30,
      "relativeTo": "Last Dose",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "b6fa6b92-9405-4c97-9d54-f9e35fed0143",
      "name": "Withhold Ramucirumab Before Surgery",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 28,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 0
    },
    {
      "id": "e8a6409a-5e68-4def-b727-4c0967e1df88",
      "name": "Proteinuria Dose Delay",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 14,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 14
    },
    {
      "id": "5161791b-a2b9-4689-a6ae-04dd63cb5883",
      "name": "Grade 3 AE Resolution Window",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 21,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 28
    }
  ],
  "conditions": [
    {
      "id": "92a2fb55-3ddc-494e-b75e-f4f1a58080f0",
      "name": "Cycle 1 Dosing Criteria - Bilirubin",
      "instanceType": "Condition",
      "description": "Hepatic function requirement for weekly dosing in Cycle 1",
      "text": "Total bilirubin 1.5x upper limit of normal (ULN) or baseline (whichever is greater)"
    },
    {
      "id": "f0dae079-40c2-4638-b8eb-ab3546fb6b9a",
      "name": "Cycle 1 Dosing Criteria - ALT/AST Low Baseline",
      "instanceType": "Condition",
      "description": "Hepatic function requirement for weekly dosing in Cycle 1 when baseline is low",
      "text": "ALT and AST 3x ULN, if baseline <1.5x ULN"
    },
    {
      "id": "45d50e28-1d57-4c14-82f7-88ff5e00bc9a",
      "name": "Cycle 1 Dosing Criteria - ALT/AST High Baseline",
      "instanceType": "Condition",
      "description": "Hepatic function requirement for weekly dosing in Cycle 1 when baseline is elevated",
      "text": "ALT and AST 2x baseline, if baseline 1.5x ULN"
    },
    {
      "id": "f28d5b26-0675-4cb1-aaaf-ec1c41a99f5d",
      "name": "New Cycle Dosing Criteria - ANC",
      "instanceType": "Condition",
      "description": "Hematologic requirement for new cycle",
      "text": "Absolute neutrophil count (ANC) 1.5x 10^3/L (1.5x 10^9/L)"
    },
    {
      "id": "ddc6d41c-2a7a-4fc6-a08d-447dfd26cffa",
      "name": "New Cycle Dosing Criteria - Platelets",
      "instanceType": "Condition",
      "description": "Hematologic requirement for new cycle",
      "text": "Platelets 100x 10^3/L (100x 10^9/L)"
    },
    {
      "id": "96ec4079-5530-4723-9363-219bbd479887",
      "name": "New Cycle Dosing Criteria - AE Resolution",
      "instanceType": "Condition",
      "description": "Adverse event resolution requirement for new cycle",
      "text": "Ramucirumab-related AEs that are NCI CTCAE v5.0 Grade <2 or equivalent severity to baseline (except for alopecia; for hypertension and proteinuria, see Section 6.5.1.8)"
    },
    {
      "id": "76476bff-81c3-4719-ba54-9ccb32b5cfcf",
      "name": "HIV Positive Eligibility",
      "instanceType": "Condition",
      "description": "Conditions for HIV positive participants to be eligible",
      "text": "HIV positive participants excluded unless well controlled on HAART with no AIDS-defining opportunistic infections within last 2 years and CD4 count >350 cells/L"
    },
    {
      "id": "62986e1e-9719-41f4-9cbd-b69b6d95fe10",
      "name": "Proteinuria UPCR Threshold",
      "instanceType": "Condition",
      "description": "Proteinuria threshold for dose modification",
      "text": "UPCR 2 (or 200 mg/mmol) requires dose modification"
    },
    {
      "id": "a3fd9f35-e428-48f7-b575-e4701e6520f5",
      "name": "Hypertension Control Requirement",
      "instanceType": "Condition",
      "description": "Hypertension must be controlled before resuming treatment",
      "text": "Hypertension controlled with medication and resolved to Grades 0-2"
    },
    {
      "id": "dabd9805-ed88-4bbf-8e41-c1c23babcdb9",
      "name": "Grade 3 AE Resolution Criteria",
      "instanceType": "Condition",
      "description": "Criteria for resuming treatment after Grade 3 AE",
      "text": "Non-life-threatening and reversible Grade 3 clinical AEs that resolve to Grade 1 or pretreatment baseline within 21 to 28 days"
    }
  ],
  "transitionRules": [
    {
      "id": "58eeb591-6732-43e8-a6e1-6592f0cc6f57",
      "name": "Discontinuation for Grade 4 AE",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "If a Grade 4 AE occurs and is deemed at least possibly related to ramucirumab, then ramucirumab should be discontinued except in the specific case of Grade 4 fever or Grade 4 laboratory abnormalities"
    },
    {
      "id": "36c5d0a8-44e1-4135-ad47-483f25eb18e2",
      "name": "Discontinuation for Treatment Delay >4 Weeks",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "If a delay of greater than 4 weekly doses is necessary due to ramucirumab-related, unresolved toxicity, ramucirumab SC should be discontinued"
    },
    {
      "id": "111381b7-393e-48cc-ba44-1600bd9efd57",
      "name": "Discontinuation for Hypersensitivity Grade 3-4",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for Grade 3-4 hypersensitivity reaction"
    },
    {
      "id": "2cbf5488-4d0d-4d9a-8881-f42df3f19580",
      "name": "Discontinuation for Uncontrolled Hypertension",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for uncontrolled hypertension, hypertensive crisis, or hypertensive encephalopathy (Grade 4)"
    },
    {
      "id": "1d3b7447-4369-48d4-ba57-0fb1114b4b19",
      "name": "Discontinuation for Arterial/Venous Thromboembolic Events",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for Grade 3 or 4 arterial or venous thromboembolic events"
    },
    {
      "id": "8d805d57-6ef2-435c-b8be-9ec53b5ae4f4",
      "name": "Discontinuation for Bleeding/Hemorrhage Grade 3-4",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for Grade 3 or 4 bleeding/hemorrhage"
    },
    {
      "id": "baa2e20f-fd87-4966-bc98-78e785b59f1e",
      "name": "Discontinuation for GI Perforation",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for gastrointestinal perforation"
    },
    {
      "id": "09d8187c-07d0-4bc5-83da-538426c44ad3",
      "name": "Discontinuation for PRES",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for posterior reversible encephalopathy syndrome"
    },
    {
      "id": "827f5818-0265-4775-920f-6ee34c198ed1",
      "name": "Discontinuation for CHF Grade 3-4",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for Grade 3 or 4 congestive heart failure"
    },
    {
      "id": "50220294-0a86-4360-b43c-a2451d464b1d",
      "name": "Discontinuation for Fistula Formation",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Immediately and permanently discontinue ramucirumab for fistula formation"
    },
    {
      "id": "67ccbebf-4c90-4d11-868a-bc4f024c54d1",
      "name": "Discontinuation for Nephrotic Syndrome",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Discontinue study treatment for proteinuria UPCR >3 (or >300 mg/mmol) or in the setting of nephrotic syndrome"
    },
    {
      "id": "1864b7d5-11fc-45e2-aa97-d59d3e0bf7e1",
      "name": "Discontinuation for Persistent Proteinuria",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "If UPCR remains 2 (or 200 mg/mmol) after 14 days, discontinue study treatment"
    },
    {
      "id": "6c8bae6a-effd-4129-a09e-b5d24f9f72f9",
      "name": "Discontinuation for Second Proteinuria Occurrence",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Second occurrence of UPCR 2: Discontinue study treatment"
    },
    {
      "id": "1a32ef9f-7fff-4ac6-b820-4510c4bb49e9",
      "name": "Discontinuation for Hepatic Encephalopathy",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Ramucirumab should be discontinued in the event of any new occurrence of hepatic encephalopathy and/or hepatorenal syndrome resulting from liver cirrhosis"
    },
    {
      "id": "1a1a430d-ea06-4cd7-8487-4e4cd52248c0",
      "name": "Dose Modification for Grade 3 AE",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Dose modifications are permitted only for ramucirumab maintenance dose in the setting of non-life-threatening and reversible Grade 3 clinical AEs considered to be at least possibly related to ramucirumab that resolve to Grade 1 or pretreatment baseline within 21 to 28 days"
    },
    {
      "id": "8ad58def-0981-4952-8a4d-44dda18311f2",
      "name": "Dose Modification for Proteinuria",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "If UPCR 2 (or 200 mg/mmol), omit ramucirumab dose until UPCR returns to <2. Resume ramucirumab at reduced dose"
    },
    {
      "id": "f51792b9-25d1-4ed2-bed3-1f216f00c8ba",
      "name": "Continuation to Monotherapy",
      "instanceType": "TransitionRule",
      "transitionType": "Arm Transition",
      "text": "If participants have discontinued combination anti-cancer therapy, ramucirumab SC may be continued as monotherapy until progressive disease, at the discretion of the investigator"
    },
    {
      "id": "c11aadc4-2971-445a-9499-04e477708704",
      "name": "Loading Dose Re-administration",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Re-administration of loading dose is required only if 30 days has elapsed since the last ramucirumab SC dose"
    }
  ],
  "scheduleTimelineExits": [
    {
      "id": "b5d6aed0-b044-4d5e-8890-3fd0cbafa8c0",
      "name": "Progressive Disease",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "Ramucirumab SC may be continued as monotherapy until progressive disease"
    },
    {
      "id": "5ce5da6d-d89d-4387-954d-45d859b9d71d",
      "name": "Life-Threatening Event",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "Ramucirumab will be permanently discontinued in case of any ramucirumab-related event that is deemed life-threatening, regardless of grade"
    },
    {
      "id": "1251b940-81c2-4771-a1b7-514f228a5f4c",
      "name": "Symptomatic Deterioration",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "Any symptomatic deterioration or clinical disease progression requiring other forms of specific antitumor systemic therapy will be cause for discontinuation of study therapy"
    },
    {
      "id": "e1ae6310-2357-432c-b773-1eefc1708d04",
      "name": "Wound Healing Complications",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "If a participant develops wound-healing complications during therapy, discontinue ramucirumab until the wound is fully healed"
    },
    {
      "id": "7e9e8ea0-3aba-4b35-b674-973fccfec903",
      "name": "Inadvertent Enrollment",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "Discontinuation of inadvertently enrolled participants"
    },
    {
      "id": "16d4412c-3add-4254-97b6-70b3ad5a06fd",
      "name": "Lost to Follow-up",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "Participant lost to follow-up"
    }
  ],
  "analysisPopulations": [
    {
      "id": "ac56318d-8b42-4a10-8f8e-040882ed5e5f",
      "name": "Entered Population",
      "populationType": "Other",
      "instanceType": "AnalysisPopulation",
      "label": "Entered",
      "description": "All participants who sign the informed consent form",
      "criteria": "Signed informed consent form"
    },
    {
      "id": "59523342-b956-4c67-ab56-3904f2e567ea",
      "name": "Enrolled/Intent-to-Treat Population",
      "populationType": "Efficacy",
      "instanceType": "AnalysisPopulation",
      "label": "ITT",
      "description": "All participants who receive at least 1 dose of study drug",
      "criteria": "Received at least 1 dose of study drug"
    },
    {
      "id": "75e8f1b9-f8c3-4638-a6d4-bd8bfe1ffd13",
      "name": "Efficacy Population",
      "populationType": "Efficacy",
      "instanceType": "AnalysisPopulation",
      "label": "Efficacy",
      "description": "All participants with evaluable disease per their baseline assessment and at least 1 complete postbaseline assessment",
      "criteria": "Evaluable disease at baseline and at least 1 complete postbaseline assessment"
    },
    {
      "id": "7a6c1fbd-3542-4475-a658-099d9a67d289",
      "name": "Safety Population",
      "populationType": "Safety",
      "instanceType": "AnalysisPopulation",
      "label": "Safety",
      "description": "All participants who take at least 1 dose of study drug. The safety population will be used for all analyses of dosing, exposure, and safety.",
      "criteria": "Received at least 1 dose of study drug"
    },
    {
      "id": "9ef7fe4c-1afc-42c1-9fce-d1451b89a391",
      "name": "Pharmacokinetic Analysis Population",
      "populationType": "Pharmacokinetic",
      "instanceType": "AnalysisPopulation",
      "label": "PK",
      "description": "All treated participants who receive at least 1 dose of study drug and have at least 1 evaluable PK sample",
      "criteria": "Received at least 1 dose of study drug and have at least 1 evaluable PK sample"
    }
  ],
  "characteristics": [
    {
      "id": "1b1fd68a-4d47-43ad-a55b-56591bbe9fb4",
      "name": "Age",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Age at baseline in years"
    },
    {
      "id": "ff9b17b5-26d6-4bb7-9263-b5a1d886bd2d",
      "name": "Gender",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Gender of participant"
    },
    {
      "id": "a47f2072-6a43-47da-8a96-3d4a7a0f3d46",
      "name": "Race",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Race of participant"
    },
    {
      "id": "4469f668-8df0-4eb0-a19e-cb436461d2a0",
      "name": "Ethnicity",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Ethnicity of participant"
    },
    {
      "id": "388f08d4-745f-4f9e-82b4-9ac40196b76c",
      "name": "Weight",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Weight at baseline in kg"
    },
    {
      "id": "3d78f66f-b138-4604-a0e5-5fad6ecab77b",
      "name": "Height",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Height at baseline in cm"
    },
    {
      "id": "15d92136-9fdd-4d04-accf-b50304903d3c",
      "name": "ECOG Performance Status",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Eastern Cooperation Oncology Group Performance Status at baseline"
    },
    {
      "id": "8e892ef4-9610-42da-9c0a-ec98d4117249",
      "name": "Alcohol Use",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Alcohol use history"
    },
    {
      "id": "46d365e8-caa6-4463-a5a1-dc41c2100849",
      "name": "Tobacco Use",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Tobacco use history"
    },
    {
      "id": "fa73b3b9-596d-464d-9a48-854a13932410",
      "name": "Pathological Diagnosis Type",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Pathological diagnosis type at initial diagnosis"
    },
    {
      "id": "a6534656-2be3-47e1-8fc8-25107f86a199",
      "name": "Duration of Disease",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Duration of disease in months"
    },
    {
      "id": "8d169dbf-3c03-4fcf-a1bd-b3908561e8c0",
      "name": "Disease Stage",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Disease stage at study entry"
    },
    {
      "id": "e071fe87-12a3-45e5-a3b8-904885818ff5",
      "name": "Histopathological Diagnosis Grade",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Histopathological diagnosis grade at study entry"
    },
    {
      "id": "e2395a5d-477e-468a-a20f-bd3a4aafc571",
      "name": "Prior Cancer Therapies",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Prior cancer therapies including surgery, radiotherapy, and systemic therapy"
    },
    {
      "id": "b7d3af02-f964-4d82-9a0f-87464947d146",
      "name": "Historical Illness",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Historical illness by MedDRA preferred term, including infusion-related reaction and hypersensitivity"
    }
  ],
  "documentContentReferences": [
    {
      "id": "c1e75d4f-b40d-409c-9b53-e629fb180721",
      "name": "Section 4.1.1 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.1.1",
      "sectionTitle": "Cohort A",
      "description": "Reference to total enrollment based on safety and PK data in Schema"
    },
    {
      "id": "ba80e9f9-3a50-4b6d-81da-742f2d27e3d8",
      "name": "Section 4.1.2 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.1.2",
      "sectionTitle": "Cohort B",
      "description": "Reference for additional details on Cohort B in Schema"
    },
    {
      "id": "71acf006-1eba-4d74-b49a-c72fb0a3b497",
      "name": "Dosing Regimen Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.3.2",
      "sectionTitle": "Rationale for Cohort B Dose Selection",
      "description": "Reference to dosing regimen details in Schema and Section 6.1"
    },
    {
      "id": "3b7260e1-1adc-4ada-9ae3-0bf9659b0496",
      "name": "Section 6.1 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.1",
      "sectionTitle": "Study Intervention(s) Administered",
      "description": "Reference to dosing regimen in Schema"
    },
    {
      "id": "e0fe8c25-d7fd-44cb-b589-5793b3e42b9c",
      "name": "Sample Size Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.2",
      "sectionTitle": "Sample Size Determination",
      "description": "Reference for sample size in Sub-Cohorts B2 and B3 in Schema"
    },
    {
      "id": "71c3764e-f64c-4549-8b87-01c443c8d15c",
      "name": "Section 10.3 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.3",
      "sectionTitle": "Adverse Events: Definitions and Procedures",
      "description": "Reference added to AE collection row in Schedule of Activities"
    },
    {
      "id": "ffbc5cf5-e3f9-48cb-8e5e-46aa15ca4a52",
      "name": "Section 9.2.2 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.2.2",
      "sectionTitle": "Cohort B Sample Size",
      "description": "Reference for recommendation to open enrollment to Cohort B"
    },
    {
      "id": "a9c48847-dc72-4d26-ac08-1dff53fb9755",
      "name": "Section 2.1 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "2.1",
      "sectionTitle": "Study Rationale",
      "description": "Reference to bioavailability calculation using available PK data"
    },
    {
      "id": "045736ea-b2f0-42b1-b84b-120a75d6a3c6",
      "name": "Appendix 4 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.4",
      "sectionTitle": "Contraceptive Guidance",
      "description": "Reference to contraceptive methods with failure rate <1% per year"
    },
    {
      "id": "f3433034-f022-4a7b-89c1-68f54feee9d4",
      "name": "Appendix 1 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.1",
      "sectionTitle": "Regulatory, Ethical, and Study Oversight Considerations",
      "description": "Reference for informed consent requirements"
    },
    {
      "id": "334a2b3d-0ce2-44dd-a537-38a1b9328cb0",
      "name": "Appendix 2 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.2",
      "sectionTitle": "Clinical Laboratory Tests",
      "description": "Reference for pregnancy testing and hypersensitivity tests"
    },
    {
      "id": "15fedef3-2139-46a6-b500-ff31f1d13770",
      "name": "Appendix 6 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.6",
      "sectionTitle": "Restricted and Prohibited Concomitant Therapy",
      "description": "Reference for aspirin use and NSAID restrictions"
    },
    {
      "id": "8541ad1d-54ac-4f03-a32c-05abe54b244c",
      "name": "Section 6.5.1.8 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.5.1.8",
      "sectionTitle": "Supportive Care by Adverse Event of Special Interest",
      "description": "Reference for hypertension and proteinuria treatment criteria"
    },
    {
      "id": "2d0e05ec-8f6c-48cf-acaa-705013523960",
      "name": "Section 6.6.1 Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.6.1",
      "sectionTitle": "AESI Dose-Modification Guidelines",
      "description": "Reference for adverse event of special interest dose-modification"
    }
  ],
  "commentAnnotations": [
    {
      "id": "ebe4d01f-c6d8-431a-8949-3a28b427902f",
      "text": "Gastrointestinal-GEJ and NSCLC participants are allowed to be on therapeutic-dose anticoagulation if they are on a stable dose (minimum duration 14 days) of oral anticoagulant or low molecular weight heparin. If receiving warfarin, the participant must have an INR 3.0 and no active bleeding.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Inclusion Criteria",
      "pageNumber": 40
    },
    {
      "id": "871c0238-b8f9-4867-b315-26ff9ecce5ad",
      "text": "Refer to Section 4.1.1 for total enrollment, based on safety and PK data.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schema",
      "pageNumber": 16
    },
    {
      "id": "652423d6-a309-4325-9f20-947dab574d5d",
      "text": "Refer to Section 4.1.2 for additional details.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schema",
      "pageNumber": 16
    },
    {
      "id": "ea15f2f6-56eb-480c-99e0-9c32c98a736b",
      "text": "Maximal proposed weekly doses are indicated. This dose will be administered once per week, with the LD given on Cycle 1 Day 1, except in Cohort B1 that will start with 875 mg SC QW MD without LD.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schema",
      "pageNumber": 16
    },
    {
      "id": "e6027938-fe46-4aee-b78c-8953d85ee7c0",
      "text": "Refer to Sections 4.3.2 and 6.1 for the dosing regimen.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schema",
      "pageNumber": 16
    },
    {
      "id": "3340c1d2-5f88-4a2f-a6b7-f05e187a311e",
      "text": "Sample size in Sub-Cohorts B2 and B3 (if opened) determined by PK and safety data, per Sections 4.1.2 and 9.2.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Schema",
      "pageNumber": 16
    },
    {
      "id": "df33e57d-6108-4b84-b2eb-8877647f89bc",
      "text": "Central venous access device placement must occur at least 7 days prior to enrollment.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Exclusion Criteria",
      "pageNumber": 42
    },
    {
      "id": "e856ad8b-7fb5-483d-b590-261e8f492bae",
      "text": "For each weekly dose in Cycle 1, the following criteria must be fulfilled to administer ramucirumab SC: Total bilirubin 1.5x ULN or baseline, ALT and AST 3x ULN if baseline <1.5x ULN, ALT and AST 2x baseline if baseline 1.5x ULN",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Treatment Requirements",
      "pageNumber": 47
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "8f8b1ab8-af1c-4e9f-a5a8-bbfb4f643954",
      "versionNumber": "e",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-02-26",
      "description": "Protocol Amendment e - substantial amendment to enable investigation of additional dosage regimens based on preliminary interim analysis data from Study I4T-MC-JVDT",
      "amendmentNumber": "Amendment e"
    },
    {
      "id": "38f45c57-afab-4332-a4fb-f2aec595f178",
      "versionNumber": "d",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-01-14",
      "description": "Protocol Amendment d",
      "amendmentNumber": "Amendment d"
    },
    {
      "id": "8b69785a-2710-4364-a725-7cdc65580e0a",
      "versionNumber": "c",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-11-05",
      "description": "Protocol Amendment c",
      "amendmentNumber": "Amendment c"
    },
    {
      "id": "50e03965-5069-4a97-bbf5-0c8231eeabf9",
      "versionNumber": "b",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-10-02",
      "description": "Protocol Amendment b",
      "amendmentNumber": "Amendment b"
    },
    {
      "id": "46e27cac-9dd7-4507-b7e2-c17338d4445b",
      "versionNumber": "a",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-09-14",
      "description": "Protocol Amendment a",
      "amendmentNumber": "Amendment a"
    },
    {
      "id": "84b2ae44-7e1a-4da3-b8da-2c03d70833f7",
      "versionNumber": "Original",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-05-21",
      "description": "Original Protocol"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "d1bc7269-15fd-4200-8466-4c629c33929a",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.1 - Synopsis",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added language to support flat dosing for Study JVDU based on preliminary interim analysis data"
    },
    {
      "id": "cd547763-154d-4059-80c7-c6e1c62e2e24",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.1 - Synopsis (Overall Design); Section 1.2 - Schema; Section 4.1.1 - Cohort A",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added language reflecting PK will also be assessed in all cohorts"
    },
    {
      "id": "9cf76d8e-6942-48aa-8c8e-63fb7b6212fc",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.1 - Synopsis (Number of Participants); Section 9.2 - Sample Size Determination",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended the range of number of study participants from 15-24 to 18-30"
    },
    {
      "id": "94ad0adc-5ae0-4650-b371-e10301861a3b",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.1 - Synopsis (Intervention Groups and Duration); Section 6.1 - Study Intervention(s) Administered",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended the Intervention Groups and Duration table and footnotes to reflect the expansion of Cohort B"
    },
    {
      "id": "2bfbf398-70e8-49b4-8be3-768a7d99d2ad",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.2 - Schema",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended Schema and footnotes to reflect the expansion of Cohort B"
    },
    {
      "id": "d57f7f03-a9b4-4760-ae11-ef35de40c3fd",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.3 - Schedule of Activities",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended note above table for clarification"
    },
    {
      "id": "1f515621-a3e2-4733-9be6-c39572edf52a",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.3 - Schedule of Activities, Continued Access Schedule of Activities",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added reference to Section 10.3 in the AE collection row"
    },
    {
      "id": "ad7bb513-4bc2-4fe6-8823-7b51e18fff4f",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.3 - Schedule of Activities",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added language stating an investigator designee may also assess the injection site assessments"
    },
    {
      "id": "23b2c250-532a-4f3f-bbea-586cfe2a6e0e",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.3 - Schedule of Activities",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended instructional language in the Administer ramucirumab row"
    },
    {
      "id": "6d076c54-2db4-49a2-8d92-226a0bbdb463",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 1.3.1 - Pharmacokinetic Sampling Schedule",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended general instructions for PK sampling"
    },
    {
      "id": "74e94871-f022-410a-8b91-aa9c54c176cf",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 2.1 - Study Rationale",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Removed language related to prior dosing rationale; Added language referencing clinical outcome and PK parameters of IV and SC dosing; Removed sentence referencing Eli Lilly's SC formulation"
    },
    {
      "id": "17123199-d1ac-4304-9358-52373508cd83",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 2.3.1 - Risk Assessment",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended language to allude to recent clinical data for SC ramucirumab"
    },
    {
      "id": "344f2484-9684-47ea-aa3b-c50e54e5a136",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 4.1 - Overall Design; Section 9.2.1 - Cohort A",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Described sub-cohorts and cohorts based on updated study design; Removed language about Study JVDT"
    },
    {
      "id": "6eff63d1-830b-4e14-86f7-6d46b9d36ad3",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 4.1.1 - Cohort A",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Removed sentence referencing participants with disease indications where ramucirumab is approved as a monotherapy"
    },
    {
      "id": "17eb1e8e-dba9-477b-bb9b-fc4acacf7f96",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 4.1.1 - Cohort A",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended language related to enrolling an additional 3 participants into Cohort A"
    },
    {
      "id": "e9a7debf-a55c-4827-a3b1-9c1aee911104",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 4.1.2 - Cohort B",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Specified additional design elements in Cohort B, which now comprises B1, B2, and B3"
    },
    {
      "id": "4e75e50e-9f43-41ca-876d-77aaa408316e",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 4.3.2 - Rationale for Cohort B (Sub-Cohorts B1, B2, and B3) Dose Selection",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added rationale for dose selection and updated dosing table (based on bioavailability of 40%) for new Sub-Cohorts B1, B2, and B3; Removed rationale for initial Cohort B dose selection"
    },
    {
      "id": "e68e8b67-a748-4707-8026-c4bcdd49bba1",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 5.1 - Inclusion Criteria",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended Inclusion Criterion 3"
    },
    {
      "id": "6c9cf056-e835-4b54-bc4b-e6d63741f80f",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 6.1 - Study Intervention(s) Administered",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added language specifying dosage in Sub-Cohort B1; Specified when interim analysis will be performed (Sub-Cohort B2); Specified ramucirumab dose may be adjusted in Sub-Cohort B3"
    },
    {
      "id": "fdb8fcd8-37e9-4cb3-adce-a2b0e7fc533d",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 6.1 - Study Intervention(s) Administered; Section 6.6 - Dose Modification",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Changed injection site reaction grading threshold and moved to Section 6.1 (from Section 6.6)"
    },
    {
      "id": "89e988bc-d190-4fe1-a006-a39b46772b20",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 6.6 - Dose Modification",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Removed language related to pausing study on the basis of a new safety signal"
    },
    {
      "id": "f39ce2a7-801c-43b6-b36c-ea83fc0a5d09",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 6.6 - Dose Modification",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added fever as an example of a non-threatening and reversible Grade 3 clinical AE; Moved language referencing Appendix 3 for AE grading to an earlier paragraph"
    },
    {
      "id": "dc2a67f5-b919-4f46-89e7-548737bf8564",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 6.6 - Dose Modification",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Added a dose reduction for the MD of the newly described dosage regimen"
    },
    {
      "id": "f3fb2276-478f-4499-912c-ac2c91fd069e",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 7.3 - Lost to Follow up",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Removed language related to collection of survival status"
    },
    {
      "id": "c3cdbdfb-390d-4cd6-826d-aa7ce95320ac",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 9.1 - Statistical Hypotheses",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Specified Ctrough and the approved dose of IV ramucirumab"
    },
    {
      "id": "960a632a-279a-4b67-9fa9-988793d80698",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "affectedSection": "Section 9.2.1 - Cohort A",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Amended number of participants/duration of PK and safety assessment required before opening enrollment for Cohort B"
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "49e0371e-6a76-4974-933d-5be290101825",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "The overall rationale for the amendment is to enable investigation of additional dosage regimens. Preliminary interim analysis data from Study I4T-MC-JVDT, a single-site study in healthy participants who received a single dose of SC or IV ramucirumab indicated a 40% bioavailability for ramucirumab following SC administration (bioavailability previously predicted: >50%). A Sub-Cohort B1 has been added to provide a second-dose level (in addition to cohort A), with the goal to generate PK data from at least 6 participants to inform dosing strategy for Sub-Cohort B2 (loading dose and maintenance weekly dose).",
      "category": "Scientific",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "e274be22-6533-4461-b0fd-b11ff3b7ceb2",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "Based on preliminary interim analysis data from Study I4T-MC-JVDT",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "116c01b0-8be0-42af-b9ae-ab7eb88fc7e7",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "Clarification",
      "category": "Administrative",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "03c008d5-e6e7-4b78-ae8f-e7d42e8f30c7",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "To account for the expansion of Cohort B, to investigate additional dosing regimens based on preliminary interim analysis data from Study I4T-MC-JVDT",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "0cbf252b-a617-4c0a-b858-cf73051dfc4d",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "To provide flexibility for sites",
      "category": "Operational",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "9ce1d349-f25a-4488-bf59-84b03734d945",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "Correction (missed in previous amendment), based on preliminary interim analysis data from Study I4T-MC-JVDT revealing lower bioavailability than the assumption, previously eligible participants for approved ramucirumab monotherapy (2L Gastric, 2L HCC) would have received sub-optimal exposure on starting Cohort A dose",
      "category": "Safety",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "f33054f4-37cb-4c4e-a9a0-442b24ef8182",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "Clarification that additional enrollment in Cohort A may occur to numerous reasons",
      "category": "Administrative",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "9449668a-f9f1-48a1-8dee-b575a5cdafbc",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "To account for the expansion of Cohort B, to investigate additional dosing regimens",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "8d4af799-e777-4983-b9a4-5857e36f9da8",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "Allowing participants with mild-to-moderate local injection site reactions due to ramucirumab SC administration to continue to receive it",
      "category": "Safety",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "25836630-0546-44f9-ac07-4e914bef49d6",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "Dose modifications are not relevant for the LD",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "12cfb73a-e4e7-4acf-b8c1-150aab127c18",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "To account for a newly added LD of 1750 mg and MD of 875 mg QW based on preliminary interim analysis bioavailability data of 40%",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "17c62b7a-335b-4215-9059-1aa17402b85a",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "reasonText": "Correction, as long-term follow-up and survival status is not being collected for this study",
      "category": "Administrative",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "3b924150-ee11-4c4d-a3e0-cc55cbb30c5c",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.1",
      "afterText": "Language to support flat dosing for Study JVDU",
      "summary": "Added language to support flat dosing based on preliminary interim analysis data from Study I4T-MC-JVDT"
    },
    {
      "id": "9582a231-b6b2-4094-8337-cf891507e2c4",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.1, 1.2, 4.1.1",
      "afterText": "PK will also be assessed in all cohorts",
      "summary": "Added language reflecting PK will also be assessed in all cohorts"
    },
    {
      "id": "c28fd71b-170d-4bec-aa38-f5c6799f4a18",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "1.1, 9.2",
      "beforeText": "15-24 participants",
      "afterText": "18-30 participants",
      "summary": "Amended the range of number of study participants from 15-24 to 18-30"
    },
    {
      "id": "3ed503c1-25a9-4369-b133-a4cc6c18983c",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "1.1, 6.1",
      "afterText": "Intervention Groups and Duration table and footnotes reflect the expansion of Cohort B",
      "summary": "Amended the Intervention Groups and Duration table and footnotes to reflect the expansion of Cohort B"
    },
    {
      "id": "09baf662-a372-4c52-849e-79707723d657",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "1.2",
      "afterText": "Schema and footnotes reflect the expansion of Cohort B",
      "summary": "Amended Schema and footnotes to reflect the expansion of Cohort B"
    },
    {
      "id": "2f108c77-352f-4d54-8f7a-642a20414b4c",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.3",
      "afterText": "Reference to Section 10.3 in the AE collection row",
      "summary": "Added reference to Section 10.3 in the AE collection row"
    },
    {
      "id": "4e688476-841b-448e-838b-af7443794380",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.3",
      "afterText": "An investigator designee may also assess the injection site assessments",
      "summary": "Added language stating an investigator designee may also assess the injection site assessments"
    },
    {
      "id": "a93b082a-fb64-477b-8069-83e36bd1126f",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "2.1",
      "beforeText": "Language related to prior dosing rationale; sentence referencing Eli Lilly's SC formulation of ramucirumab",
      "afterText": "Language referencing clinical outcome and PK parameters of IV and SC dosing of ramucirumab in Study I4T-MC-JVDT",
      "summary": "Removed language related to prior dosing rationale; Added language referencing clinical outcome and PK parameters; Removed sentence referencing Eli Lilly's SC formulation"
    },
    {
      "id": "ad27e57a-1338-4f77-bb0f-a8259746a8a2",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "2.3.1",
      "afterText": "Language alluding to recent clinical data for SC ramucirumab",
      "summary": "Amended language to allude to recent clinical data for SC ramucirumab"
    },
    {
      "id": "14aed4c9-8645-4eda-809b-734f08a4c70f",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "4.1, 9.2.1",
      "beforeText": "Language about Study JVDT",
      "afterText": "Described sub-cohorts and cohorts based on updated study design",
      "summary": "Described sub-cohorts and cohorts based on updated study design; Removed language about Study JVDT"
    },
    {
      "id": "1e2ad6c0-f81a-4f80-a979-40ca054d2b49",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Deletion",
      "instanceType": "StudyChange",
      "sectionNumber": "4.1.1",
      "beforeText": "Sentence referencing participants with disease indications where ramucirumab is approved as a monotherapy",
      "summary": "Removed sentence referencing participants with disease indications where ramucirumab is approved as a monotherapy"
    },
    {
      "id": "07e26b09-c13f-49eb-8ec0-6be10acb1e33",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "4.1.2",
      "afterText": "Cohort B now comprises B1, B2, and B3 with additional design elements",
      "summary": "Specified additional design elements in Cohort B, which now comprises B1, B2, and B3"
    },
    {
      "id": "1e53d8c9-eb33-4b66-bfdb-cdd3e3669312",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "4.3.2",
      "beforeText": "Rationale for initial Cohort B dose selection",
      "afterText": "Rationale for dose selection and updated dosing table (based on bioavailability of 40%) for new Sub-Cohorts B1, B2, and B3",
      "summary": "Added rationale for dose selection and updated dosing table for new Sub-Cohorts; Removed rationale for initial Cohort B dose selection"
    },
    {
      "id": "7d1cbc81-d34b-48a5-ae4e-95d1c50a14fb",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "5.1",
      "afterText": "Amended Inclusion Criterion 3",
      "summary": "Amended Inclusion Criterion 3 for clarification"
    },
    {
      "id": "4b1cc378-1de5-4fd0-8294-fe256c3d4de2",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "6.1",
      "afterText": "Language specifying dosage in Sub-Cohort B1; when interim analysis will be performed (Sub-Cohort B2); ramucirumab dose may be adjusted in Sub-Cohort B3",
      "summary": "Added language specifying dosage in Sub-Cohort B1, interim analysis timing for Sub-Cohort B2, and dose adjustment for Sub-Cohort B3"
    },
    {
      "id": "1dc752c7-1e6b-4f3f-9779-3e14d98104be",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "6.1, 6.6",
      "beforeText": "Injection site reaction grading threshold in Section 6.6",
      "afterText": "Changed injection site reaction grading threshold and moved to Section 6.1",
      "summary": "Changed injection site reaction grading threshold and moved from Section 6.6 to Section 6.1"
    },
    {
      "id": "b43ecdd2-3599-4c6d-9783-68a051f420ac",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Deletion",
      "instanceType": "StudyChange",
      "sectionNumber": "6.6",
      "beforeText": "Language related to pausing study on the basis of a new safety signal",
      "summary": "Removed language related to pausing study on the basis of a new safety signal"
    },
    {
      "id": "4e62594c-bc2f-47a4-b2cc-8348e3107296",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "6.6",
      "afterText": "Fever as an example of a non-threatening and reversible Grade 3 clinical AE",
      "summary": "Added fever as an example of a non-threatening and reversible Grade 3 clinical AE"
    },
    {
      "id": "8b6b9c94-51e6-4c99-8654-c7acaac55a0a",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "6.6",
      "afterText": "Dose reduction for the MD of the newly described dosage regimen (LD of 1750 mg and MD of 875 mg QW)",
      "summary": "Added a dose reduction for the MD of the newly described dosage regimen based on 40% bioavailability data"
    },
    {
      "id": "a69210f3-ba89-45e5-a2a2-9876bcbf8b8d",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Deletion",
      "instanceType": "StudyChange",
      "sectionNumber": "7.3",
      "beforeText": "Language related to collection of survival status",
      "summary": "Removed language related to collection of survival status"
    },
    {
      "id": "54d08614-12c5-4658-9c80-bca61b453777",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "9.1",
      "afterText": "Specified Ctrough and the approved dose of IV ramucirumab",
      "summary": "Specified Ctrough and the approved dose of IV ramucirumab for clarification"
    },
    {
      "id": "7d8473b5-28f3-4b19-9554-02863380191d",
      "amendmentId": "687e4892-3a5f-4002-a963-d9164c4e8d60",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "9.2.1",
      "afterText": "Amended number of participants/duration of PK and safety assessment required before opening enrollment for Cohort B",
      "summary": "Amended number of participants/duration of PK and safety assessment required before opening enrollment for Cohort B"
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "issues_found"
  }
}